hg_150674.1

Basic information about the TSS

---

TSS ID: hg_150674.1 Species: human Chr: chr15		Start: 68817606 End: 68817633 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000495764.1 Distance: 0 GeneID: 8125 HGNC/MGI_ID: HGNC:13233 UniProt_ID:

Gene_name: acidic nuclear phosphoprotein 32 family member A Gene_symbol: ANP32A Gene_synonyms: I1PP2A LANP MAPM PHAPI PP32 mapmodulin Gene_source: HGNC:13233

TATA-Box annotation

---

Distance to TSS:	3275
Nearest PromoterID:	NM_006305
Entrez ID:	8125
Nearest Unigene:	Hs.458747
Nearest Refseq:	NM_006305
Nearest Ensembl:	ENSG00000140350
Gene Name:	acidic nuclear phosphoprotein 32 family member A
Gene Alias:	C15orf1|HPPCn|I1PP2A|LANP|MAPM|PHAP1|PHAPI|PP32
Gene Description:	acidic nuclear phosphoprotein 32 family member A
Gene Type:	protein-coding
CpG%:	0.075
GC%:	0.577114
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ANP32A p2@ANP32A p3@ANP32A p4@ANP32A p5@ANP32A p6@ANP32A p7@ANP32A p8@ANP32A
Sample		p1@ANP32A	p2@ANP32A	p3@ANP32A	p4@ANP32A	p5@ANP32A	p6@ANP32A	p7@ANP32A	p8@ANP32A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.82	9.93	22.60	3.31	1.17	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.26	11.94	26.91	4.86	0.20	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	19.48	11.19	31.06	4.24	1.74	0.39	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.93	7.48	24.33	2.91	1.25	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.57	6.07	27.22	2.92	0.90	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.86	8.53	25.97	3.10	0.78	0.39	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	24.40	13.29	34.21	4.36	2.40	0.22	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.04	9.20	32.94	4.36	0.24	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	26.07	8.76	22.44	3.63	1.07	0.00	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	3.48	18.55	1.16	1.16	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.87	1.62	19.40	0.40	0.81	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	1.63	21.55	0.41	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	18.38	3.22	1.29	3.22	1.45	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.08	4.81	0.90	4.96	0.90	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.27	3.95	1.98	3.95	0.22	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.07	5.03	1.26	2.26	1.51	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.86	3.28	1.31	3.93	0.66	0.44	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.33	2.53	1.27	0.42	0.42	0.00	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.40	2.67	1.60	2.67	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.65	4.51	1.65	4.21	0.90	0.00	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.76	4.28	1.87	2.67	1.47	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.08	4.32	1.38	5.52	0.86	0.35	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.73	2.97	1.68	2.33	0.90	0.00	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.68	3.15	2.18	3.64	0.24	0.00	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.35	2.84	0.77	4.13	0.52	0.00	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.44	4.75	1.27	6.01	0.95	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.79	4.40	0.55	3.85	0.00	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.91	4.24	2.59	5.66	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.44	3.55	1.62	1.29	1.62	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.30	2.35	0.90	4.34	0.90	0.00	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.68	2.72	2.30	1.47	0.42	0.00	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.57	2.93	1.56	1.76	1.17	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.71	2.11	0.63	1.48	1.27	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.33	5.28	1.65	1.81	0.99	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.97	3.18	1.50	1.87	1.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.96	4.22	0.19	0.77	0.96	0.19	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.63	3.47	2.25	4.09	0.20	0.20	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.08	1.81	1.01	2.22	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.34	4.32	2.70	2.70	1.89	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.84	3.36	1.20	3.84	1.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.06	1.41	0.94	3.76	0.47	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.83	3.22	1.17	2.93	0.88	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.86	4.22	1.05	4.22	1.05	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.57	2.97	0.52	2.27	0.17	0.00	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	15.06	2.61	1.61	3.21	0.80	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.21	4.42	2.56	3.72	1.40	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.12	1.68	1.68	1.20	0.72	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.54	3.87	1.79	4.17	0.89	0.00	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.46	2.87	1.91	2.39	0.00	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.89	2.22	1.01	2.43	0.81	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.27	2.25	1.23	1.43	1.43	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.34	2.45	0.67	1.33	0.67	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	153.91	27.98	13.99	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.10	1.77	1.42	0.71	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	1.33	0.66	0.33	0.66	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	9.23	5.87	5.03	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	2.30	1.84	2.30	0.00	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.78	2.27	0.65	0.65	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.67	0.64	0.96	0.32	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.20	3.14	1.89	0.63	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	1.41	0.71	0.71	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	1.68	2.24	0.56	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.05	7.17	2.39	0.80	3.18	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.91	2.72	1.70	1.36	0.34	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.75	1.30	1.30	0.97	2.27	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.45	1.42	1.06	0.35	1.42	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	96.98	80.82	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	47.38	39.49	31.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	1.95	0.49	0.98	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	1.98	0.50	1.49	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.20	2.35	0.00	2.81	1.88	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.89	2.65	1.66	2.98	0.99	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	0.93	0.62	0.62	0.62	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.92	1.22	1.22	0.92	1.22	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	9.82	3.17	1.74	1.58	0.95	0.48	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	8.98	3.85	2.25	1.60	0.64	1.44	0.16	0.48
Adipocyte - omental, donor1	11473-119C6	10.81	2.16	1.65	2.54	0.89	1.02	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	8.97	1.49	2.24	0.00	1.49	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	9.38	1.34	3.01	2.01	0.33	0.67	0.00	1.34
Adipocyte - perirenal, donor1	11476-119C9	8.93	0.00	0.64	3.19	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	4.40	1.10	2.20	0.00	1.10	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	23.48	4.97	2.26	4.06	1.35	0.90	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	13.73	5.73	3.30	1.91	0.17	1.39	0.00	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	30.90	10.56	3.91	6.85	1.76	1.96	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	12.35	3.86	1.54	1.29	1.29	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	20.35	7.25	1.95	1.39	0.56	0.84	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	22.34	7.64	4.11	2.35	0.59	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	32.58	14.16	6.03	23.16	2.57	3.22	0.00	2.33
Adipocyte differentiation, day08, donor2	13023-139D8	16.46	5.16	1.61	5.81	2.26	1.29	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	8.00	4.80	3.73	0.00	2.13	0.00	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	5.56	2.23	2.78	3.90	0.56	0.00	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	20.79	2.50	1.66	5.41	1.25	2.08	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	17.33	6.03	3.01	2.01	1.51	1.26	0.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	14.07	3.27	1.96	2.29	0.65	3.60	0.00	2.29
Adipocyte differentiation, day12, donor4	13030-139E6	17.96	2.44	2.44	2.44	1.83	2.74	0.00	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	22.76	3.76	3.76	2.65	1.10	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	6.45	1.08	0.72	0.00	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20	1.20	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	16.37	3.06	5.94	2.34	1.44	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	3.35	3.35	3.35	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.68	1.85	2.88	2.26	0.82	0.00	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	27.23	5.49	4.81	2.29	0.23	0.34	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	17.14	0.49	0.98	1.47	1.22	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	2.25	3.15	1.80	0.90	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.85	1.74	2.17	2.17	1.30	0.87	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	0.00	8.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.36	2.99	4.48	2.39	0.00	0.00	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	3.79	2.53	2.53	0.00	1.26	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	10.56	1.32	3.96	1.32	0.66	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	2.92	2.92	3.25	0.97	0.65	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.77	0.97	2.91	0.97	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	4.16	1.78	1.78	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	2.64	4.52	1.88	0.38	0.38	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	2.90	3.63	2.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	0.00	3.76	1.25	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.86	2.64	3.29	3.13	0.82	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	1.36	5.46	4.09	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.10	2.71	2.41	2.56	1.21	0.60	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	3.21	3.21	0.54	0.00	0.54	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.45	2.83	2.08	2.08	1.32	0.38	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.23	3.21	3.74	3.21	1.34	0.27	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	2.93	5.85	3.90	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.44	1.66	2.32	2.49	0.33	0.66	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	1.20	2.40	2.40	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	14.16	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.40	2.40	2.23	2.23	0.34	0.17	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	1.94	4.37	3.40	0.00	0.97	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.94	3.42	3.42	3.79	1.14	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	1.21	1.21	4.85	2.42	0.00	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	3.99	1.71	0.57	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.25	1.07	2.14	1.92	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.29	3.10	2.06	2.32	0.26	0.52	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.38	0.47	1.88	1.41	0.94	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.47	2.57	0.96	1.29	0.32	0.32	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	0.71	1.43	2.14	2.14	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	1.75	2.92	0.58	0.58	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.04	2.11	1.81	1.81	1.51	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	2.38	3.56	1.19	4.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	5.09	4.58	2.03	0.51	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.01	1.27	3.06	2.80	1.78	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	3.18	1.27	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.95	3.02	2.59	1.29	1.29	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.85	2.75	1.48	2.54	0.21	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	2.90	1.45	2.32	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	0.00	3.78	3.78	0.94	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.05	1.86	3.56	2.71	0.85	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	4.23	0.00	6.34	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.65	1.07	3.86	1.50	0.00	0.21	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	3.01	0.60	1.80	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	2.19	2.19	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.87	3.45	3.91	2.30	0.46	0.46	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.42	2.03	0.76	1.27	0.76	0.25	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.77	1.65	2.48	1.65	0.83	0.41	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.87	1.53	1.22	1.84	0.92	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	11.47	3.35	2.87	1.43	0.00	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.09	1.77	1.11	0.67	0.00	0.44	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	0.00	1.53	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	2.77	1.66	2.77	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.92	2.12	3.71	0.79	1.06	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	0.73	3.27	1.45	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	22.60	1.60	8.60	2.82	0.74	0.37	0.00	0.37
Astrocyte - cerebellum, donor2	11580-120F5	13.18	2.40	1.88	0.51	1.54	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	11.54	1.47	2.73	1.26	0.63	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	55.43	16.38	27.54	6.97	2.44	0.70	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	49.02	19.09	15.37	9.22	3.56	0.81	0.97	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	42.96	15.21	21.63	5.67	2.39	0.15	0.45	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	136.93	27.41	18.92	21.56	10.32	0.80	1.15	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	143.82	29.69	20.30	27.69	11.15	0.50	0.50	1.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	139.29	28.22	20.26	25.38	8.76	0.80	0.23	1.02
Basophils, donor1	12241-129G9	37.14	8.37	2.09	4.97	1.83	0.52	0.00	0.00
Basophils, donor2	12242-129H1	33.19	17.68	5.05	7.22	4.33	0.00	0.00	0.72
Basophils, donor3	12243-129H2	40.57	9.41	2.06	12.05	0.88	0.00	0.15	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	13.80	0.65	0.43	0.43	0.43	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	0.00	0.46	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	23.85	0.63	3.77	1.88	0.63	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	17.68	1.46	2.08	0.83	0.62	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	13.82	0.92	2.07	1.15	0.69	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	23.57	1.08	2.52	0.90	0.90	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	78.73	29.47	27.62	17.83	5.67	0.00	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	101.55	19.56	15.60	19.80	8.15	0.70	0.70	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	58.20	35.50	17.91	15.99	5.12	1.92	0.00	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	31.03	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	35.50	10.71	0.56	3.38	1.69	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	24.31	5.01	1.67	4.08	1.11	0.56	0.00	0.56
CD14+ Monocytes, donor3	11381-118B4	25.47	7.68	0.66	3.07	1.76	0.66	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	49.82	9.91	7.93	9.06	3.68	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	41.32	7.96	1.90	5.69	2.27	0.76	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	42.74	9.53	6.25	4.27	1.97	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	24.28	6.79	2.02	3.32	0.58	1.45	0.14	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	15.69	3.32	0.60	4.22	0.60	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	26.53	5.69	0.47	2.84	0.71	0.47	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	14.56	3.68	1.17	3.52	1.00	0.00	0.17	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.21	5.80	0.55	2.48	0.83	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.90	3.22	1.24	2.98	0.25	0.00	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.27	3.52	1.57	2.94	0.78	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	19.76	6.77	1.78	2.49	0.71	0.00	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	18.28	6.96	0.87	4.57	1.52	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.79	4.45	1.40	2.58	1.40	0.23	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.42	5.28	1.06	2.64	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	9.98	1.11	3.33	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.58	5.50	1.49	3.42	0.89	0.15	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.98	2.99	0.60	1.20	0.40	0.00	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	14.16	4.37	0.83	2.71	1.46	0.42	0.21	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.50	4.58	0.92	2.52	1.14	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.83	5.88	1.58	3.39	0.45	0.00	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16.15	3.49	2.62	2.62	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.33	4.30	0.27	2.69	1.08	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	21.11	6.28	2.09	4.01	0.87	0.00	0.17	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.15	8.00	0.42	2.95	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.06	4.78	1.47	3.12	0.92	0.55	0.37	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.39	6.34	1.41	2.11	0.70	0.70	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	19.30	3.07	0.88	2.63	0.44	0.44	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	18.31	2.79	1.05	3.49	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	24.53	5.58	1.49	4.46	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	27.37	6.04	1.08	4.53	0.43	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.47	2.05	0.41	4.91	0.82	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.70	6.72	1.39	4.40	0.70	0.23	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	15.78	4.87	2.32	4.64	1.16	0.00	0.00	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	51.66	10.46	3.27	8.28	3.49	1.09	0.00	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	47.35	12.24	2.31	6.24	3.93	0.23	0.69	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	51.34	11.26	4.55	6.07	2.60	0.43	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	52.79	14.95	3.27	10.74	4.20	0.47	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	54.84	16.24	2.62	9.26	3.84	0.35	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	74.92	13.82	2.23	12.26	4.24	0.22	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	43.38	12.25	2.81	8.42	1.53	0.26	0.00	1.53
CD14-CD16+ Monocytes, donor2	11800-124C9	39.74	10.76	3.29	9.22	3.73	0.66	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	54.95	10.74	2.95	9.26	3.58	0.84	0.84	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	71.13	16.26	14.23	12.19	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	69.15	38.64	17.63	15.59	2.71	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	96.31	31.07	13.46	13.46	2.07	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	63.43	36.78	10.13	12.79	1.60	0.00	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	95.42	47.71	14.47	11.79	3.75	2.14	0.00	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	59.66	30.89	10.53	7.02	1.40	1.40	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	75.30	29.81	11.77	10.20	2.35	0.78	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	96.23	30.32	21.09	11.86	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	42.74	10.68	6.58	6.58	2.47	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	39.90	5.80	3.63	3.63	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	39.38	8.58	5.55	2.52	0.50	0.00	0.50	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	96.97	27.07	13.74	14.95	4.04	0.40	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	77.10	23.57	6.79	10.39	2.80	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	23.09	12.05	6.02	8.03	4.02	3.01	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	24.72	5.62	3.93	3.93	0.56	0.00	0.56	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	76.28	28.93	22.55	25.93	4.88	0.75	0.38	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	69.22	45.32	23.22	18.26	2.25	0.23	0.23	1.13
CD4+ T Cells, donor1	11225-116C1	55.34	10.00	7.14	6.43	1.43	0.71	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	45.31	6.74	3.67	2.45	1.22	0.00	1.22	1.22
CD4+ T Cells, donor3	11382-118B5	32.33	6.40	3.05	1.83	1.22	0.91	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	57.94	12.76	2.55	8.17	3.32	0.77	0.26	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	54.35	12.13	1.35	8.76	2.92	1.12	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	56.34	11.21	2.01	4.89	2.87	1.44	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	56.42	13.75	14.70	9.96	2.37	0.00	0.00	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	54.08	18.96	7.73	7.73	3.51	1.40	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	6.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	51.74	10.69	5.20	8.96	3.18	1.01	0.00	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.53	9.83	3.90	6.10	3.73	1.02	0.00	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	42.24	9.35	2.42	6.45	2.10	0.48	0.64	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	44.38	10.76	7.17	3.59	2.69	1.79	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	46.82	10.83	5.59	6.99	2.10	2.10	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	55.00	10.12	5.72	6.60	3.52	1.76	0.00	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	49.33	12.23	6.32	8.43	2.95	1.69	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	47.58	11.64	3.74	6.03	3.12	0.62	0.42	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	41.10	13.70	3.01	6.68	4.01	1.34	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	52.76	16.04	10.88	5.17	2.72	0.27	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	51.99	12.33	9.11	6.97	1.61	0.54	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	17.93	7.17	12.55	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	62.86	14.09	4.82	7.97	3.89	0.74	0.37	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	47.44	11.70	4.12	6.93	1.08	0.65	0.22	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.91	12.82	2.31	5.04	3.99	1.47	0.42	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	50.56	16.18	6.57	5.06	3.54	2.53	0.00	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	63.69	12.56	6.07	9.10	3.47	3.47	0.87	3.90
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	63.63	16.13	7.84	12.20	1.31	2.61	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	68.29	24.25	11.38	10.89	4.95	2.97	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	55.39	15.69	12.00	7.39	1.85	2.77	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	26.52	11.17	6.98	1.40	2.79	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	70.62	9.42	13.29	7.20	3.05	0.55	0.00	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	80.24	8.10	14.97	7.85	3.44	1.23	0.00	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	63.14	23.10	9.24	13.86	6.16	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	78.07	17.91	9.67	7.16	3.94	2.51	0.00	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	72.02	27.70	6.92	11.08	1.38	5.54	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	37.32	16.37	5.89	2.95	1.64	2.95	0.00	2.95
CD8+ T Cells, donor2	11307-117C2	27.78	8.26	7.13	3.00	0.38	0.75	0.00	1.50
CD8+ T Cells, donor3	11383-118B6	47.72	9.34	5.81	3.53	0.76	1.51	0.50	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.86	4.13	4.59	1.61	3.44	0.23	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.52	2.64	5.27	2.16	1.44	1.68	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	24.62	3.83	4.65	4.92	1.37	0.82	0.27	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	35.42	5.40	9.01	3.00	2.70	2.10	0.30	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.36	3.60	4.08	4.56	2.64	1.68	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.24	2.27	6.37	3.18	2.96	1.14	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.99	3.04	8.04	3.48	3.04	1.30	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	32.37	2.37	6.58	4.47	2.90	0.53	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.07	4.46	7.04	3.28	3.28	0.70	0.23	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	34.72	5.74	9.66	4.83	5.74	1.51	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	30.21	4.36	10.75	6.39	2.91	1.16	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.02	3.46	6.66	5.60	4.80	0.27	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.14	1.31	3.06	1.75	1.31	0.88	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	1.82	5.92	1.82	1.37	1.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	24.61	0.00	2.24	1.49	2.98	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	32.77	2.88	5.76	2.52	3.60	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	28.48	2.59	5.18	2.30	2.30	0.86	0.00	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.39	1.41	5.19	3.54	1.18	0.71	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	40.25	4.75	10.14	3.80	2.85	1.90	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	36.60	2.77	10.46	3.38	1.54	1.54	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.21	5.13	4.81	3.85	4.17	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	34.04	3.44	7.27	3.82	2.29	1.53	0.00	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	31.92	2.36	7.09	4.34	4.73	1.97	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	5.29	3.78	4.54	0.76	0.00	0.00	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	3.21	10.44	4.82	0.80	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.28	4.20	6.29	0.00	2.10	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	3.01	8.01	1.00	8.01	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	14.62	0.00	5.48	3.66	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	18.78	8.40	6.42	1.98	0.49	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	29.36	8.73	5.05	14.21	0.95	0.32	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	15.60	3.47	2.43	1.04	2.08	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	12.44	1.78	2.49	2.13	1.07	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.52	3.07	2.28	1.71	1.25	0.68	0.23	0.46
Chondrocyte - re diff, donor2	11339-117F7	39.39	9.85	4.48	2.69	3.58	2.69	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	18.20	4.85	2.02	1.21	0.81	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	32.36	13.43	16.07	5.05	1.95	0.69	0.00	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	25.01	9.19	6.41	2.99	0.43	0.64	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	28.41	8.58	7.70	4.96	1.86	0.18	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	27.24	9.26	6.51	4.68	1.65	2.11	0.00	0.64
Corneal Epithelial Cells, donor1	11526-119I5	14.49	1.10	0.66	1.10	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	22.75	1.14	1.14	3.41	4.55	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	20.71	3.83	1.53	2.30	1.28	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.22	2.15	1.32	5.61	2.97	1.49	0.17	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.96	2.21	1.89	3.78	4.42	0.63	0.00	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	0.00	6.90	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.41	2.59	1.94	3.78	3.78	1.51	0.54	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	53.64	26.99	13.32	9.57	2.05	0.68	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	59.41	25.46	9.14	5.88	2.61	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	53.72	13.55	17.42	4.84	0.97	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	23.85	4.34	4.17	2.50	1.50	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	5.28	1.76	0.59	1.76	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.40	3.11	4.24	2.55	0.85	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.58	1.57	3.15	1.57	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	22.11	3.20	2.91	6.11	1.16	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	31.53	9.65	6.59	4.00	1.18	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	24.02	4.38	5.61	2.10	1.23	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.28	8.42	4.88	6.43	1.11	0.44	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.60	4.26	4.87	3.96	0.91	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.14	5.36	4.51	4.79	2.82	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	18.72	1.19	5.65	2.97	0.59	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.58	2.08	3.64	0.52	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	12.90	2.55	3.12	1.56	0.99	0.57	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	29.21	3.60	11.60	3.60	1.20	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	20.96	2.62	1.57	1.05	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	58.15	17.27	24.10	11.31	4.22	0.75	0.50	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	53.45	10.43	12.38	8.26	4.56	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	54.71	9.40	10.26	4.03	2.32	0.37	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	14.79	3.41	4.55	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	12.57	3.49	4.19	2.10	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	22.77	5.02	6.12	4.08	1.26	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	15.25	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	163.38	21.45	16.50	42.91	6.60	8.25	0.00	8.25
Eosinophils, donor3	12246-129H5	149.81	24.97	7.13	21.40	17.83	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	10.75	0.73	2.20	1.71	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	3.28	0.82	1.64	0.41	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.47	1.64	0.33	1.20	0.33	0.22	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.70	1.73	1.30	1.52	0.43	0.22	0.33	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	23.89	9.10	6.43	4.97	1.09	0.49	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	12.96	5.05	1.36	8.05	0.82	0.14	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.66	3.27	2.00	2.21	0.32	0.11	0.21	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.38	1.84	1.32	1.84	0.53	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.24	4.98	1.99	1.00	1.33	0.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	23.13	2.27	3.18	3.18	0.45	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	19.71	3.03	3.79	1.52	2.27	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.45	5.05	3.94	1.58	1.10	0.47	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	28.49	8.79	3.64	3.94	2.73	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	33.38	4.19	5.58	3.81	1.65	0.63	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	31.68	3.79	3.49	3.18	1.36	0.76	0.15	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.74	1.74	4.15	0.94	0.80	0.40	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.37	2.59	4.31	2.16	1.73	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	4.39	7.32	2.93	4.39	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	31.14	2.31	6.46	2.31	1.85	0.46	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	18.49	7.46	2.37	3.22	1.02	0.85	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	19.02	2.11	2.58	3.29	0.70	0.47	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	18.87	5.19	4.25	1.42	1.42	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	21.88	4.96	2.90	1.93	1.33	0.48	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	55.84	4.75	10.29	2.83	4.18	0.00	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	50.59	7.68	13.08	5.58	2.79	0.00	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	63.51	7.63	13.16	5.85	3.25	0.32	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	36.44	7.08	5.62	4.79	1.67	0.42	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.17	4.19	3.67	4.98	1.83	0.52	0.00	0.79
Fibroblast - Gingival, donor2	11318-117D4	39.40	9.22	8.83	5.27	2.24	0.40	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	33.45	6.77	3.58	3.48	1.45	0.29	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	28.05	3.12	1.04	2.08	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.98	3.35	1.59	1.76	1.23	0.53	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.07	5.46	2.49	3.90	2.03	0.47	0.16	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	25.96	4.46	2.30	2.84	2.43	0.14	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	5.65	2.82	0.71	1.06	0.71	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.15	2.78	2.92	2.63	2.19	0.44	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.32	6.82	4.23	3.41	1.64	0.27	0.00	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	30.06	7.35	3.51	5.16	1.97	0.44	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.34	3.67	1.61	2.93	0.29	0.15	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	12.23	1.36	4.08	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	4.48	5.97	0.00	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	30.60	7.39	8.44	4.43	0.84	1.06	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	19.16	0.83	5.00	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	0.00	1.40	0.00	1.40	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	5.60	0.00	0.56	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	30.45	3.25	4.47	4.06	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	53.15	14.16	11.83	6.21	3.88	0.39	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	61.28	14.86	16.69	6.67	4.25	0.30	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	43.45	5.51	4.28	4.59	2.14	0.92	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.52	5.72	1.91	4.58	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	3.24	2.70	2.16	0.54	0.54	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.26	3.94	1.51	1.51	1.16	0.35	0.00	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.73	8.73	6.30	6.52	0.99	0.77	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.68	1.22	2.03	3.05	1.83	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	2.67	3.34	2.00	2.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.16	5.14	1.19	2.37	0.79	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.83	2.38	4.17	3.77	1.59	0.00	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.56	4.62	2.49	2.84	1.42	0.00	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.26	5.72	2.76	2.76	0.99	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.56	3.31	3.61	2.71	1.20	0.30	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.28	3.35	6.59	1.94	1.84	0.43	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.26	1.52	3.29	1.52	1.52	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	17.39	4.43	3.61	2.79	1.97	0.82	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.86	6.02	3.21	8.82	1.60	0.00	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	31.75	3.62	9.34	2.91	1.91	0.60	0.00	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	30.83	4.23	2.72	2.42	2.12	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.07	6.21	3.65	2.57	1.57	0.50	0.00	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.29	1.88	4.27	1.37	0.85	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.08	2.96	2.63	0.99	0.99	0.00	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	35.05	3.52	7.35	4.47	1.49	0.96	0.00	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	32.22	7.59	7.93	4.22	1.86	0.51	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.19	7.53	4.39	8.63	0.94	0.94	0.16	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	132.96	155.12	44.32	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.09	2.61	1.74	0.87	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.91	2.77	1.21	2.08	1.39	0.52	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.26	1.56	1.56	2.08	0.26	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	19.42	2.04	1.53	1.53	1.02	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	70.43	13.78	5.36	6.89	9.19	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	81.04	14.68	10.85	11.49	7.02	0.00	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	159.75	15.12	7.99	21.97	12.27	0.57	2.28	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	104.24	18.48	16.27	14.06	7.17	0.28	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	66.21	16.67	14.61	12.79	7.53	0.23	1.14	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	90.35	12.48	5.15	12.48	6.74	0.40	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	92.78	15.60	15.33	12.16	9.78	0.00	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	65.88	11.42	12.39	5.54	8.15	0.33	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	130.46	13.71	4.86	19.90	7.96	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	87.05	11.73	9.33	7.35	5.51	0.28	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.28	12.93	15.27	4.80	2.22	0.25	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	65.54	8.60	7.52	12.63	4.84	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.18	11.65	16.35	6.81	2.97	0.12	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	66.44	10.52	13.29	4.98	5.12	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	56.92	8.95	5.29	8.95	4.07	0.20	0.81	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	27.15	12.09	14.83	6.16	2.74	0.00	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	44.97	11.58	12.08	5.36	3.99	0.25	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.77	10.05	5.46	5.46	2.62	0.66	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	34.57	19.80	15.66	7.39	1.18	0.00	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.17	16.05	22.89	5.25	2.86	0.00	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	38.20	10.95	9.38	5.14	2.68	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	35.49	16.74	20.16	8.87	2.82	0.20	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	45.80	20.87	31.55	7.97	3.05	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	45.67	22.17	21.46	12.68	2.66	0.18	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.99	18.73	19.15	7.08	2.29	0.10	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.89	12.13	13.49	5.98	1.37	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	45.92	18.92	23.57	5.09	2.66	0.33	0.44	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	42.35	19.55	22.63	11.15	2.16	0.25	0.00	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.08	14.70	18.17	11.23	1.84	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	32.39	15.47	16.50	8.05	1.65	0.00	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.44	18.68	21.56	6.57	2.31	0.46	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	35.35	13.34	13.34	7.00	2.17	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.48	8.60	12.56	5.07	1.10	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.79	18.08	16.48	6.40	2.21	0.00	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	25.61	12.97	14.26	6.65	2.27	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	10.26	11.87	3.85	0.96	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.53	12.79	20.85	4.74	1.80	0.00	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.21	9.49	13.92	4.59	2.06	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	32.54	11.56	8.82	4.56	1.82	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.88	14.01	17.88	3.66	2.61	0.42	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.91	8.56	9.22	6.37	1.76	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	25.25	11.50	11.50	4.21	2.24	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.20	7.96	12.13	3.33	1.85	0.09	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.00	6.69	8.02	5.08	1.34	0.53	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.02	8.11	11.02	5.05	0.46	0.15	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.51	7.90	14.38	3.37	0.39	0.00	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.11	5.69	11.11	4.07	1.63	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.28	10.14	13.46	4.61	1.11	0.00	0.18	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.22	8.33	10.53	4.61	1.75	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	9.92	9.92	3.97	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.62	8.05	8.84	3.83	1.06	0.00	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.75	6.25	6.66	3.63	0.61	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	24.91	11.69	9.66	4.57	1.02	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	140.34	8.76	11.55	15.33	9.75	0.20	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	79.35	10.48	5.39	8.01	5.39	0.46	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	122.95	17.18	5.93	12.27	10.23	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	83.24	16.59	7.51	19.40	5.63	0.63	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	80.53	21.47	8.48	17.52	6.22	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	83.48	7.84	4.15	8.30	1.84	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	86.62	19.80	7.42	17.32	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	89.35	30.56	22.82	20.50	4.64	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	11.23	19.25	11.23	6.42	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	12.17	24.34	15.65	3.48	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.95	31.25	22.78	14.65	5.21	0.65	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	82.77	23.06	19.77	18.53	1.65	0.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	33.32	13.33	0.00	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	55.65	20.41	21.81	11.47	3.64	0.28	1.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	76.48	21.90	22.23	16.34	3.27	0.98	1.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	58.72	28.52	20.13	18.45	5.87	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	54.39	26.72	21.63	13.04	2.54	0.00	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	67.93	27.85	22.76	12.57	3.06	0.00	2.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	45.94	31.32	25.06	12.53	2.09	2.09	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.03	26.92	24.05	10.88	2.29	0.57	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	55.05	21.01	15.39	10.06	2.37	0.00	2.07	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	30.49	32.19	6.78	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	60.89	31.89	40.59	14.91	4.14	0.41	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	51.55	29.46	34.29	12.20	4.14	0.00	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	21.07	36.88	10.54	5.27	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	39.21	24.99	25.76	9.23	3.84	0.00	2.69	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	37.16	27.06	25.43	4.24	0.98	0.00	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.81	12.04	13.38	6.02	3.34	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	34.67	30.82	25.04	10.40	3.08	0.00	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.84	20.54	23.62	6.85	1.71	0.00	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	22.36	17.39	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	44.83	21.23	14.63	9.44	2.36	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	42.24	19.92	19.92	6.64	3.02	0.00	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	42.73	20.35	26.96	6.61	4.07	0.51	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.05	23.93	26.32	8.38	2.79	0.00	1.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	45.88	27.63	27.13	8.39	0.49	0.49	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	44.86	27.15	28.33	12.98	4.72	0.00	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	29.76	17.50	15.75	7.58	2.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.48	22.38	18.43	4.39	1.32	0.00	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.15	27.97	22.04	5.09	0.85	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	35.22	25.67	23.28	3.58	1.79	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	11.16	32.03	4.37	3.40	0.00	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	3.42	1.14	2.28	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.24	3.33	0.83	1.66	1.25	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	5.62	0.00	0.00	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	2.85	1.59	1.90	0.63	1.27	0.32	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	1.25	1.67	1.25	0.42	2.09	0.00	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.11	6.50	6.27	6.15	2.32	0.35	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.54	5.40	5.91	5.74	2.70	0.00	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	43.23	5.69	6.83	5.69	2.73	0.46	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.59	7.11	7.11	5.36	3.39	0.33	0.22	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.39	6.66	6.88	4.08	3.22	0.21	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	41.33	4.74	7.53	3.44	2.58	0.22	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	27.02	3.99	6.10	4.61	1.87	0.25	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.10	4.80	4.29	2.40	2.06	0.17	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.00	4.49	3.20	4.49	2.24	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.35	0.56	5.04	1.68	3.36	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	2.16	1.73	0.43	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00	7.93	0.00	2.64	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.64	2.12	3.17	2.12	1.06	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	1.45	2.18	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.43	7.52	4.90	3.85	1.22	0.35	0.00	0.17
Hepatocyte, donor1	11523-119I2	24.21	1.21	6.05	8.47	1.21	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	24.78	4.31	6.46	1.08	3.23	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	30.06	6.14	5.52	3.07	0.61	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	67.88	36.55	55.48	9.79	5.22	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	38.98	15.38	16.08	9.26	2.27	1.05	0.52	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	30.73	6.72	4.94	10.02	0.96	0.14	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	1.38	1.38	4.15	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	11.87	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	5.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	0.00	1.62	1.62	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	0.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	2.65	2.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	3.33	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.93	2.52	1.89	2.52	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	1.55	7.73	0.00	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	3.88	1.29	1.29	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	0.00	4.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	4.07	2.44	1.63	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	16.79	2.94	2.94	1.68	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	25.72	4.82	5.63	2.41	3.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	18.47	3.69	3.69	2.77	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	26.43	3.78	3.30	1.89	1.42	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	22.67	4.53	1.81	0.91	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	21.52	5.38	3.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	2.54	2.54	5.08	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	3.83	1.91	0.64	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	7.29	7.29	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	20.71	5.00	0.00	1.43	2.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	0.00	13.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	26.54	3.09	4.32	2.16	1.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	3.51	0.00	1.76	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	0.00	0.00	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	19.47	0.70	2.78	1.39	2.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	2.21	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	26.16	6.10	1.74	0.87	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	2.25	4.50	2.25	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	5.33	3.20	3.20	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	0.00	2.77	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	15.65	0.92	2.76	1.84	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	2.11	2.11	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	22.28	5.06	2.45	4.57	1.80	0.08	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	7.61	0.59	0.59	0.59	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	41.36	4.64	3.22	4.45	2.27	0.00	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	44.95	9.76	4.88	6.24	2.50	0.11	0.00	0.00
Keratocytes, donor1	11527-119I6	28.88	7.91	7.56	2.41	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	14.06	3.52	1.17	1.17	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	24.50	8.50	4.74	1.78	1.98	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	123.08	4.40	15.39	4.40	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	10.79	6.47	3.24	2.16	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	36.21	13.26	16.95	7.96	1.73	0.35	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	23.81	4.64	4.54	4.94	1.01	0.20	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	21.23	3.44	3.08	2.49	0.59	1.07	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.00	2.23	2.51	2.79	1.12	0.56	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.89	5.67	5.35	4.72	1.73	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.75	0.54	2.15	1.08	0.54	1.08	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.98	3.78	0.63	1.26	1.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.69	3.56	3.99	2.16	0.86	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.06	2.87	2.87	0.82	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.35	0.51	1.01	1.77	0.76	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.22	1.97	2.96	2.96	0.99	0.00	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.49	4.35	0.79	1.58	1.19	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.38	5.62	2.71	2.13	0.19	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.33	2.22	1.11	2.04	0.37	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	17.07	1.74	3.14	1.74	1.05	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.12	1.43	2.86	2.15	0.48	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.16	3.30	3.57	2.33	1.10	0.00	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	14.47	2.77	2.16	0.62	0.62	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	0.94	0.94	1.87	0.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.81	2.20	2.20	1.65	1.28	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.47	2.96	3.29	2.96	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	2.05	2.93	2.34	0.88	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.71	2.99	1.99	2.74	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.12	1.45	2.91	1.94	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.39	2.96	1.89	1.89	1.89	0.81	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	14.68	2.88	2.88	3.03	1.67	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.00	2.07	2.07	3.11	1.04	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	13.19	2.09	5.44	2.72	0.63	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.74	2.86	3.01	1.50	0.75	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	2.06	3.44	2.06	2.06	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.17	3.39	1.69	2.45	0.38	0.38	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.83	3.71	2.76	2.01	0.64	0.32	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.44	2.42	2.42	3.88	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.28	2.98	2.98	1.98	1.32	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.40	3.22	1.98	1.98	0.74	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.99	1.85	2.59	3.33	0.74	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.65	1.48	2.47	4.69	0.99	0.74	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.72	2.89	0.82	1.37	0.55	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.08	4.50	0.96	2.89	1.93	0.64	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.13	3.35	3.65	2.74	1.52	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	15.68	4.90	3.08	3.22	1.26	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	2.84	1.78	4.62	1.78	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	2.91	1.94	2.42	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.16	2.02	2.33	1.71	0.47	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.32	2.86	3.22	2.51	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.11	3.92	3.92	1.63	1.31	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	1.18	1.88	1.88	0.71	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.52	4.33	4.58	3.84	1.11	0.62	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.99	1.54	2.05	2.05	0.00	0.26	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.44	2.39	2.09	1.79	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	4.53	2.27	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	3.84	0.77	3.07	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	1.48	2.97	1.48	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	14.39	3.39	2.12	3.39	3.81	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	5.63	0.70	0.70	0.70	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	4.67	0.00	0.93	3.74	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	11.85	3.61	1.03	3.61	2.58	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	26.17	3.57	2.38	3.57	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.42	5.43	0.90	3.85	0.45	0.45	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.45	5.53	2.33	5.23	1.74	0.58	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	8.10	2.70	1.80	0.45	0.00	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.12	4.20	2.30	3.66	1.90	0.27	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.97	3.59	1.54	2.05	2.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.29	3.88	2.47	3.18	1.76	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	18.66	6.00	0.67	5.33	0.67	0.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	17.32	3.57	1.02	1.53	2.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.48	5.07	3.20	2.67	1.87	0.53	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	27.96	4.53	3.40	4.72	1.13	0.38	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	3.68	2.45	3.07	0.61	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.83	5.71	1.63	4.89	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	28.53	8.33	2.92	5.00	1.25	0.83	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.66	4.76	3.92	4.76	1.96	0.28	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	21.64	0.00	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.06	4.35	3.77	4.64	2.32	0.58	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.74	3.59	2.09	4.19	1.49	1.49	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.77	3.32	4.98	4.98	1.11	0.00	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.92	5.30	2.47	2.83	1.06	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.81	4.43	3.32	3.69	0.37	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	0.00	3.45	3.45	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	24.56	3.84	2.30	3.45	2.30	1.15	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.68	2.83	3.40	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	4.92	0.82	2.46	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	4.07	2.26	4.52	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	2.87	0.72	6.46	2.15	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	27.64	6.72	2.24	2.24	2.24	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.55	3.72	1.86	4.46	1.49	1.11	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.25	4.31	2.15	2.15	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	5.99	2.57	1.71	0.86	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.32	4.33	3.00	3.33	1.67	0.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	20.51	1.81	3.62	2.41	1.81	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	21.33	6.40	2.13	2.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.65	3.44	1.03	3.09	1.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.32	2.68	0.54	4.29	1.07	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	2.69	0.00	5.39	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.11	6.30	2.59	2.22	1.11	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	5.81	1.16	3.49	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	3.17	2.12	3.17	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.01	5.20	2.00	4.00	2.00	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	2.18	2.18	2.18	0.73	1.45	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	2.30	0.77	4.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	3.45	1.48	1.48	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	0.00	0.00	1.88	0.94	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.59	3.52	1.51	1.51	1.01	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	20.28	6.31	2.25	2.25	0.90	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.81	3.12	0.45	3.56	0.89	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.64	3.91	1.96	2.74	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.85	3.30	0.00	0.66	1.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.31	3.11	2.59	2.59	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	19.69	2.63	3.50	5.25	1.75	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.21	5.03	1.68	1.12	1.68	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.55	3.97	2.21	2.65	3.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	6.94	0.77	2.31	0.77	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	2.03	2.53	1.01	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	21.15	2.88	0.96	0.00	0.48	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.07	5.96	1.99	3.98	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	2.43	1.82	1.82	0.61	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	2.77	0.00	0.69	0.69	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.60	4.18	2.66	4.56	1.14	0.76	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.59	2.07	3.61	0.52	2.07	0.52	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	1.21	0.60	3.02	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.25	6.02	4.12	4.44	1.90	0.95	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.19	4.80	3.20	3.73	1.60	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	1.72	1.15	2.87	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	3.09	1.54	5.14	1.54	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	20.51	4.95	1.41	2.12	0.71	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.75	1.70	1.70	1.70	1.13	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	25.79	5.41	2.91	3.33	1.25	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	0.78	0.78	3.92	0.00	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	1.25	5.01	1.67	1.67	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.84	3.25	0.46	2.79	0.46	1.39	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	3.35	2.01	6.02	2.01	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.18	2.67	3.21	3.74	0.00	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	24.25	3.23	3.23	4.04	2.42	0.81	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	8.26	3.67	2.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	1.78	1.78	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	22.79	3.42	2.28	6.27	3.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	2.30	0.77	0.77	3.07	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	25.72	4.38	4.92	4.38	1.64	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	19.60	2.67	3.12	4.01	1.78	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	19.50	3.90	3.12	5.20	1.82	0.26	0.26	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	1.99	1.33	3.32	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	6.24	0.00	6.24	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	41.48	5.93	1.82	4.56	3.19	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	25.14	2.02	2.20	3.12	2.02	1.47	0.37	0.73
Macrophage - monocyte derived, donor3	11389-118C3	33.95	4.06	1.97	3.28	3.80	1.44	0.00	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	13.28	2.66	3.19	2.66	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	19.33	2.38	1.11	1.90	1.11	0.32	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	29.74	2.50	4.45	3.47	1.25	0.28	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	32.98	5.38	5.68	2.29	1.49	1.00	0.10	0.70
Mammary Epithelial Cell, donor2	11350-117G9	31.85	2.61	4.05	3.19	1.45	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	18.96	2.24	1.50	2.00	0.75	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	89.49	38.64	16.95	12.88	5.42	3.39	0.00	6.10
Mast cell, donor1	11563-120D6	53.10	16.76	5.08	7.89	2.60	0.54	0.11	0.43
Mast cell, donor2	11565-120D8	53.79	11.59	3.86	6.54	2.38	1.78	0.00	0.89
Mast cell, donor3	11566-120D9	60.78	15.31	4.95	6.08	1.80	2.93	0.00	1.58
Mast cell, donor4	11567-120E1	46.63	10.28	4.25	14.54	1.95	1.95	0.00	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	48.68	8.87	4.21	5.10	2.00	0.89	0.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	19.85	3.50	3.50	4.09	1.17	2.33	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	47.72	12.50	3.21	8.95	3.56	0.46	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	36.49	7.03	2.68	4.02	3.01	0.00	0.00	0.33
Melanocyte - dark, donor1	11502-119F8	37.81	10.65	8.16	8.26	2.19	0.40	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	22.15	5.54	6.92	3.11	1.04	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	37.96	9.92	11.01	8.62	2.39	1.96	0.07	0.80
Melanocyte - light, donor1	11274-116H5	11.05	2.35	2.59	0.47	0.71	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	12.28	1.36	1.36	1.36	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.01	2.60	2.60	0.87	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	34.57	5.41	3.75	3.96	1.67	0.21	0.00	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	19.90	6.72	4.03	5.11	1.08	0.54	0.00	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	20.62	8.30	5.36	4.55	1.07	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	31.64	3.60	7.69	1.98	1.74	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	19.37	3.96	6.16	2.64	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	30.16	12.31	10.60	8.07	1.96	0.73	0.16	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	35.64	11.41	11.41	8.84	2.28	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.45	1.81	1.41	0.70	0.60	0.10	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	0.00	2.62	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	31.57	4.31	2.15	7.18	3.59	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.71	2.96	1.48	3.39	0.64	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	1.01	3.02	3.52	0.50	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.34	1.76	4.18	1.98	1.32	0.44	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	23.38	2.92	2.92	2.92	2.92	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.57	1.84	2.25	2.05	0.61	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	20.50	0.97	4.43	1.39	1.52	0.14	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	1.49	0.37	0.37	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.68	5.79	4.34	3.29	1.32	0.79	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.83	0.30	0.89	0.59	0.00	0.00	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	4.48	3.20	1.92	1.92	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.53	7.09	6.38	5.32	3.90	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.77	5.32	8.44	3.13	0.63	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	40.64	2.90	7.98	8.71	2.18	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	12.99	1.33	1.86	3.18	1.33	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	14.01	3.00	1.50	1.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.79	1.23	1.01	1.37	0.65	0.29	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	39.16	0.00	1.35	5.40	5.40	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	40.39	5.17	1.72	7.63	2.71	0.49	0.00	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	27.38	2.94	0.29	4.42	2.94	2.06	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.04	2.79	1.24	4.34	1.24	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.78	1.66	1.24	1.66	1.87	0.62	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	30.53	4.00	2.00	3.25	1.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	28.39	2.33	0.93	3.26	4.65	1.86	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	30.69	1.42	2.03	3.66	2.24	0.81	0.00	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.59	3.17	2.77	4.36	4.75	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	0.88	0.88	4.42	0.88	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.94	1.52	1.52	5.32	1.52	2.66	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	1.32	0.00	0.00	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.31	3.61	0.85	3.18	1.70	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	0.00	0.92	2.76	0.00	1.84	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	19.97	2.98	1.19	3.87	0.60	0.60	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	1.68	1.68	1.68	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.07	4.01	1.76	3.01	1.25	0.25	0.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.59	1.66	0.71	4.28	1.66	1.66	0.24	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	19.35	0.55	1.11	1.11	3.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	20.95	2.30	1.61	1.38	0.00	0.46	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.46	0.84	0.42	4.21	1.89	1.47	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.66	1.43	1.02	2.65	1.22	0.82	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.52	3.43	1.50	2.57	0.64	0.64	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.89	1.78	0.44	2.89	0.89	0.89	0.00	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.67	1.31	1.10	1.10	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	3.04	0.51	1.01	2.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	0.00	0.00	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.96	2.45	1.09	1.90	1.36	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.06	2.06	0.59	4.12	1.47	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	0.00	0.00	0.00	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	1.92	0.96	0.96	0.48	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.21	1.60	0.40	2.40	0.00	1.20	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	0.00	0.00	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	1.00	1.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	2.04	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.88	0.00	0.44	0.44	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	0.00	2.21	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.09	0.64	0.00	0.00	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.45	0.74	0.99	0.25	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	0.70	1.39	1.39	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	0.00	0.00	2.21	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.65	1.03	1.03	1.71	0.68	0.68	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.25	0.88	0.00	0.44	0.44	0.88	0.00	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	18.11	0.71	1.42	0.71	2.13	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.75	1.40	1.12	3.65	1.40	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.30	0.83	0.42	1.25	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	1.17	0.58	0.58	1.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	1.21	0.90	1.21	0.30	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	0.42	0.83	0.00	0.83	0.83	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	0.92	1.85	1.85	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.09	0.57	2.28	1.71	0.57	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.83	2.07	2.07	3.87	2.63	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	1.81	1.04	1.30	1.30	0.78	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	16.30	0.86	0.86	1.72	1.29	0.86	0.00	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	21.60	1.91	0.64	0.64	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	1.33	1.60	1.33	1.33	0.53	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	21.25	0.30	0.30	1.80	2.69	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	20.20	1.13	1.13	1.27	2.26	0.14	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	13.70	0.32	2.55	0.32	0.64	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.77	1.33	0.44	3.10	1.99	0.66	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.89	0.76	0.38	2.28	3.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	1.14	1.99	1.14	0.85	0.28	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.40	1.97	1.23	1.97	2.21	0.25	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	37.15	0.00	1.96	1.96	3.26	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.70	1.76	1.76	1.18	1.47	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.62	1.73	0.86	3.17	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	30.91	3.30	4.53	3.71	1.65	0.41	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.84	1.49	3.57	0.60	1.49	0.89	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	1.78	0.00	1.78	3.56	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.80	5.91	5.26	3.94	3.29	0.66	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	4.21	1.05	3.16	1.05	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.09	5.93	2.17	6.13	2.77	0.00	0.59	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	3.73	2.79	1.86	3.73	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.92	15.02	3.76	6.38	2.63	1.50	0.00	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.18	2.40	0.53	2.13	1.60	1.33	0.80	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	32.01	5.43	1.47	3.73	2.04	0.34	0.23	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	12.52	2.95	1.47	2.21	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.78	6.96	1.83	5.86	1.10	0.73	1.10	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	4.67	0.00	4.67	1.56	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	35.27	5.88	3.74	5.34	3.21	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	21.21	3.03	2.02	4.04	2.02	2.02	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.50	3.37	2.53	3.79	0.84	0.42	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	32.69	8.17	0.00	1.36	1.36	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	26.07	5.09	3.81	2.54	2.54	0.00	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	29.96	8.91	5.67	4.86	1.62	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	7.55	0.00	0.00	3.02	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	6.52	13.05	3.26	3.26	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	9.50	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.96	3.66	3.66	2.80	0.86	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.34	10.45	5.75	5.23	1.57	0.52	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	3.34	2.67	4.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.03	0.83	0.42	0.83	1.25	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	55.52	9.70	8.37	12.17	3.42	0.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	81.39	9.58	3.19	6.38	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	2.72	0.00	0.68	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	79.02	18.38	5.51	12.86	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	2.51	0.84	1.67	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	27.20	1.63	0.70	1.16	1.16	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	3.78	0.00	2.16	1.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.81	2.10	2.10	2.10	1.26	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	133.62	22.27	33.40	0.00	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	3.47	2.48	1.99	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.70	5.41	1.35	1.08	1.08	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.29	1.81	0.91	1.59	0.91	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.96	1.47	0.33	0.82	0.98	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.77	4.01	2.19	1.09	0.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	2.12	2.12	0.00	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	2.40	0.60	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	37.74	6.89	3.61	3.28	1.97	0.00	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.87	0.98	0.33	1.46	0.65	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.93	2.29	2.12	1.23	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	0.00	0.70	0.00	2.11	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	0.46	1.84	0.92	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.28	1.93	0.64	2.57	1.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	35.87	9.66	4.83	3.45	2.07	0.34	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	22.76	22.76	17.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.26	2.23	2.23	1.34	1.34	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	2.96	0.85	0.85	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.23	3.09	1.19	3.09	1.42	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.74	1.72	0.43	2.58	1.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	36.11	27.08	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.00	2.67	1.67	1.33	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.82	1.35	1.80	0.90	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	1.19	0.79	0.00	1.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	1.86	1.86	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.05	4.92	1.89	3.41	1.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.78	0.65	1.30	0.65	0.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.84	1.74	0.87	0.44	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.57	1.81	1.81	1.36	1.81	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	1.76	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	0.66	0.00	0.66	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	1.98	0.99	0.99	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.34	1.53	0.00	2.68	0.77	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	25.10	6.96	2.42	4.84	1.51	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.45	2.43	1.55	1.11	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	2.03	0.00	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	45.99	20.44	0.00	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.24	0.61	0.00	1.83	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	1.57	0.63	1.26	0.94	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.92	1.82	0.00	0.30	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	1.58	0.00	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	11.34	2.27	5.67	2.27	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	15.17	20.23	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	17.76	4.84	3.73	2.98	2.36	0.87	0.12	0.37
Myoblast, donor2	11322-117D8	25.70	5.56	4.41	3.07	0.77	0.00	0.38	0.19
Myoblast, donor3	11398-118D3	22.20	5.04	4.04	3.20	1.68	0.67	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	57.64	23.93	26.85	11.38	2.48	1.61	0.00	1.61
Natural Killer Cells, donor1	11230-116C6	31.67	17.22	7.38	6.15	0.62	1.54	0.31	2.77
Natural Killer Cells, donor2	11311-117C6	27.44	10.86	3.02	3.02	1.81	1.21	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	29.26	10.49	4.97	2.21	0.37	2.02	0.00	2.21
Neural stem cells, donor1	11275-116H6	31.58	22.87	21.78	11.25	2.54	1.45	0.36	0.73
Neural stem cells, donor2	11352-117H2	55.84	32.74	46.22	7.70	7.70	1.93	0.00	0.00
Neurons, donor1	11494-119E9	38.69	23.90	23.90	2.28	2.28	1.14	0.00	0.00
Neurons, donor2	11574-120E8	41.61	30.38	22.90	10.57	2.20	0.66	0.44	0.00
Neurons, donor3	11655-122E8	18.91	18.09	24.66	4.11	3.29	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	131.78	21.34	5.57	24.13	10.21	3.71	3.71	1.86
Neutrophils, donor2	11314-117C9	113.06	5.80	5.80	17.39	14.49	0.00	23.19	0.00
Neutrophils, donor3	11390-118C4	207.69	22.60	4.89	30.54	11.61	2.44	2.44	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	23.27	7.60	4.39	3.21	0.59	0.59	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	14.65	2.93	1.95	2.60	0.00	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	21.66	1.40	3.41	0.80	0.80	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.56	3.03	0.83	1.10	1.10	0.14	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	14.47	2.75	2.46	1.88	1.45	0.43	0.58	0.14
Olfactory epithelial cells, donor3	11935-125I9	12.49	1.82	1.14	1.59	0.34	0.34	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	17.04	3.80	0.88	0.97	1.27	0.10	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	25.28	6.02	8.43	11.43	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.61	2.98	2.34	1.06	0.64	0.43	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	12.57	2.29	1.14	2.29	1.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	4.97	1.24	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	18.18	4.69	6.45	3.13	1.37	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	49.16	11.24	9.83	4.21	2.11	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	20.62	4.62	3.55	2.13	1.07	0.53	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	24.26	6.15	4.21	4.04	1.85	0.67	0.25	0.25
Pericytes, donor1	11491-119E6	7.34	1.34	2.78	0.56	0.22	0.00	0.00	0.22
Pericytes, donor2	11571-120E5	7.92	0.45	2.04	0.91	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	11.60	3.46	1.83	2.24	1.22	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	33.34	8.70	4.86	10.62	1.13	0.34	0.45	0.11
Perineurial Cells, donor2	11579-120F4	29.90	9.11	10.03	13.99	0.92	0.00	0.09	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	56.42	12.43	4.78	7.01	1.91	0.64	0.32	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	33.79	8.33	3.67	6.12	2.45	0.49	0.24	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	36.37	10.74	3.62	4.92	1.04	0.39	0.13	0.65
Placental Epithelial Cells, donor1	11278-116H9	15.55	3.11	2.63	1.20	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	12.20	0.00	3.33	2.22	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	20.03	6.09	6.87	1.96	0.59	0.20	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.11	0.63	1.27	1.27	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	5.82	2.06	0.94	0.94	0.75	0.56	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.31	2.87	0.65	4.44	0.78	0.00	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	10.13	3.15	1.13	2.03	0.45	0.45	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	8.21	2.24	1.07	2.13	0.43	0.32	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	8.73	2.18	2.18	2.62	0.87	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	19.91	3.87	1.43	3.29	1.15	0.43	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	8.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.76	2.15	1.54	0.61	0.61	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	33.11	5.84	4.60	4.60	2.12	0.35	0.71	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	22.82	3.24	3.07	3.07	1.02	0.34	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	35.95	9.04	5.87	5.03	2.42	0.47	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	23.01	2.76	5.06	3.22	1.84	0.00	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	23.93	4.28	3.55	3.66	1.36	0.21	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	29.57	14.48	22.33	8.75	1.21	0.75	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	16.39	2.17	2.71	3.25	1.62	0.27	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	22.72	2.69	2.02	2.57	2.33	0.06	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	26.08	8.09	5.92	8.54	1.25	0.34	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	24.38	5.02	4.48	5.02	2.15	0.72	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	12.30	1.56	1.15	1.25	0.73	0.21	0.10	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	1.46	2.55	3.28	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.46	3.33	2.56	3.33	2.01	0.21	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	11.67	1.01	1.01	2.54	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.94	3.56	2.13	3.56	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	27.52	7.30	4.23	5.40	2.54	0.85	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	0.68	2.04	1.36	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.87	0.81	4.31	1.75	1.08	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.41	7.77	9.10	5.33	1.33	0.89	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	2.00	2.00	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	18.71	3.30	4.40	1.54	1.54	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	16.30	1.88	3.13	0.63	1.88	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.10	2.22	1.11	1.11	0.83	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	30.60	1.88	1.34	3.49	1.61	0.54	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.18	1.69	2.11	0.42	1.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	17.74	3.86	1.74	1.35	2.12	0.00	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.00	6.48	7.78	6.22	2.59	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.49	3.98	2.27	2.27	0.85	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	14.41	3.09	4.12	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.81	6.27	3.51	3.26	2.26	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	36.88	9.49	6.28	7.48	2.67	2.94	0.00	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	24.12	4.47	5.36	2.68	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.38	20.36	9.91	9.36	1.65	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	56.27	12.76	8.12	4.06	2.32	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.14	5.33	16.25	5.46	2.47	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	32.97	10.63	9.93	4.17	3.28	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	45.73	17.96	12.27	9.26	4.13	0.22	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	63.39	12.65	18.11	8.56	3.10	0.25	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.69	11.54	10.14	5.71	3.61	0.23	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	50.16	13.17	10.63	6.70	4.62	0.46	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	34.64	4.93	9.17	3.56	2.05	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	41.60	15.13	9.53	6.96	2.72	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.68	11.47	8.78	4.30	3.23	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	36.01	5.45	8.89	3.16	1.58	0.00	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	36.59	11.91	10.19	4.61	2.25	0.32	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	41.38	11.73	7.74	4.65	3.32	0.00	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	31.54	4.59	6.69	2.68	1.53	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	40.15	10.43	9.97	5.68	1.77	0.28	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	45.10	18.60	13.15	11.46	3.38	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	41.14	2.79	7.30	2.39	2.52	0.13	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.98	10.90	10.12	4.77	2.34	0.19	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	42.01	11.08	9.93	6.11	2.29	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	39.09	2.88	9.18	3.95	1.82	0.00	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	32.52	7.85	8.97	1.40	1.12	0.56	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	38.96	10.42	9.74	4.10	2.05	0.68	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.91	5.29	5.47	2.73	0.91	0.18	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	31.88	8.46	8.22	4.29	2.58	0.00	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	39.49	13.30	8.87	4.97	3.36	0.13	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	4.48	7.08	4.01	1.42	0.71	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	31.94	10.91	5.56	6.55	2.78	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	39.05	7.25	7.95	3.98	2.81	0.47	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	31.10	6.22	8.71	2.90	0.83	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.97	9.95	9.51	6.86	2.43	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	39.69	7.10	7.52	3.76	2.72	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.74	6.19	7.67	2.29	3.10	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	41.55	10.56	5.11	5.96	2.72	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	38.75	9.45	7.33	3.86	2.89	0.00	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.23	5.85	8.25	3.78	1.38	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	31.41	8.23	8.64	5.35	3.15	0.41	0.41	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.82	14.45	8.87	6.73	1.64	0.16	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.14	6.31	7.16	2.22	1.19	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.98	12.43	14.06	8.14	3.26	0.44	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.18	9.06	8.26	6.40	2.67	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	39.54	5.95	5.95	1.94	2.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	34.05	8.57	8.33	4.05	2.38	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	42.32	6.05	6.45	5.04	2.82	0.00	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	28.16	3.20	5.84	3.96	1.51	0.09	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	41.57	10.13	8.38	5.24	2.10	0.35	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.64	8.76	4.84	3.32	2.72	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	31.33	2.81	3.43	1.84	2.57	0.37	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	46.87	15.43	8.01	8.30	4.80	2.33	0.29	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	39.55	11.56	7.30	3.65	2.43	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	33.15	3.01	5.12	2.11	1.21	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	25.33	10.18	5.20	4.52	1.58	0.45	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.35	9.29	5.39	4.19	2.40	0.30	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.59	1.89	8.50	3.07	1.53	0.24	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	29.24	6.62	5.98	2.99	1.49	0.64	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	40.27	4.81	6.01	3.00	3.61	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	14.67	1.69	1.69	1.50	0.94	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	20.41	0.00	13.61	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.57	3.29	6.79	1.75	0.44	0.00	0.44	0.44
Sebocyte, donor1	11220-116B5	33.96	5.48	3.83	1.64	2.19	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	23.90	4.60	4.60	4.60	2.30	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	11.95	2.06	1.86	2.47	1.03	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	33.13	3.31	3.31	4.97	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.83	12.84	4.57	3.70	2.02	0.18	0.18	0.18
Skeletal Muscle Cells, donor2	11358-117H8	7.95	0.72	1.45	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.90	3.34	6.69	0.84	5.02	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	48.23	5.50	8.95	3.93	2.67	0.63	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	42.07	6.69	8.77	2.82	3.72	0.15	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	51.40	5.69	9.54	5.08	2.15	0.00	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.28	10.46	9.70	6.30	1.51	1.39	0.50	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.53	6.28	5.14	3.85	1.43	0.71	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	55.66	14.09	11.11	10.52	2.68	0.50	0.20	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.53	9.44	7.58	5.81	1.26	0.42	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	2.90	3.62	0.72	1.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.77	2.20	2.89	0.83	0.41	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	107.44	16.12	0.00	8.06	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.81	2.74	1.87	1.15	0.86	0.14	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	0.82	0.82	0.00	0.00	1.64	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.74	1.82	1.82	0.26	1.17	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	22.10	3.75	2.78	5.14	2.22	0.00	0.00	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	22.36	1.69	4.78	1.97	1.41	0.14	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	24.32	1.06	3.38	3.17	2.75	0.21	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	21.96	2.17	2.85	2.70	1.50	0.15	0.00	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.27	0.93	1.23	0.93	0.93	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.45	0.89	1.33	2.00	2.00	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	2.35	2.35	1.76	1.76	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.43	4.64	3.54	3.09	0.66	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.78	1.97	1.18	0.79	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7.73	2.32	3.09	0.77	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	1.00	4.00	2.00	1.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.04	2.93	2.66	0.93	0.40	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.62	2.88	3.77	2.22	1.33	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	19.59	2.05	2.69	0.77	1.79	0.13	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.14	7.49	6.19	2.93	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.90	3.54	3.54	1.18	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.67	2.85	1.14	0.57	0.14	0.00	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.78	0.33	0.81	0.49	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.61	3.96	2.44	0.61	0.61	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.87	4.55	0.76	1.26	0.76	0.25	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	116.29	12.24	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.31	1.91	2.38	0.48	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.58	3.69	2.21	2.65	2.06	0.15	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.00	3.87	4.09	2.15	1.08	0.43	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.08	5.67	4.51	3.99	1.47	0.10	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.69	1.70	2.01	1.86	0.46	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	0.00	1.08	1.08	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.43	0.30	2.39	2.99	0.90	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	11.95	2.73	0.68	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.99	8.01	5.18	4.48	1.81	0.47	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.42	4.03	3.93	2.72	1.01	0.60	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.84	2.96	1.59	2.05	0.68	0.46	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	1.21	3.02	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	66.76	13.51	16.96	11.39	3.18	0.26	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	30.76	2.26	5.06	2.00	1.60	0.40	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.91	4.26	2.88	2.63	2.00	0.13	0.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.65	3.04	1.27	1.52	0.25	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.45	4.07	1.81	2.86	0.75	0.15	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	0.75	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	74.95	9.05	12.92	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.88	4.65	0.93	0.93	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	0.50	4.04	2.02	1.51	1.51	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.89	0.94	1.25	1.25	0.63	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	1.77	0.59	0.29	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	44.49	10.50	8.41	17.99	2.33	0.67	0.00	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.68	2.80	1.40	1.40	1.40	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.67	2.59	3.45	2.30	0.72	0.00	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	21.42	3.31	3.31	2.04	1.53	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.17	2.07	3.38	1.50	0.94	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.18	8.24	11.32	7.41	2.38	0.28	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.06	4.69	3.10	8.30	1.51	0.08	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.64	4.65	4.65	1.47	0.49	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.25	1.55	2.87	1.10	0.88	0.22	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.36	2.93	2.34	2.34	0.29	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.66	3.11	1.55	0.97	0.97	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.78	1.85	1.59	1.59	1.06	0.26	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.39	4.84	1.49	0.74	0.37	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.86	2.87	1.44	0.00	0.36	1.08	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.50	2.56	1.14	1.42	1.14	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.45	7.09	2.76	4.73	1.58	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.68	2.29	2.03	1.02	1.27	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	11.18	1.60	2.00	0.40	0.40	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	0.84	0.84	0.84	0.84	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	7.79	3.67	1.38	1.38	0.92	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	11.95	2.19	2.86	2.36	0.67	0.67	0.00	0.34
Synoviocyte, donor2	11368-117I9	12.07	2.85	1.68	0.67	1.17	1.84	0.17	0.34
Synoviocyte, donor3	11440-118H9	9.38	1.56	0.45	0.22	1.12	0.00	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	33.95	5.36	6.07	2.14	2.50	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	15.05	3.24	2.55	1.16	1.16	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	25.23	3.44	2.87	2.80	1.72	0.22	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	15.08	2.32	2.32	0.77	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.17	0.57	0.00	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.15	8.73	4.67	5.41	1.97	2.58	0.00	0.49
Urethra, donor2	10319-105A4	35.97	1.80	5.40	1.80	3.60	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.38	0.27	1.59	1.59	0.53	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	9.21	0.80	1.20	0.80	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.94	0.46	0.69	0.69	0.23	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	20.28	2.67	2.45	4.24	2.23	0.45	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	76.52	11.57	9.79	17.80	5.34	0.89	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	4.29	8.58	21.44	1.43	0.00	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	62.29	11.64	2.05	8.90	3.42	2.74	1.37	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	49.24	16.87	5.85	13.08	3.44	2.07	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	55.78	16.27	4.65	18.59	5.81	1.74	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	60.39	2.08	5.21	13.54	10.41	1.04	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	61.49	7.34	3.67	9.18	4.59	0.00	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	37.43	5.48	5.48	7.30	0.91	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	47.12	10.86	13.32	5.06	4.56	0.99	0.49	0.37
Wilms' tumor cell line:HFWT	10597-108E3	53.68	12.32	6.16	1.76	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.58	3.91	2.79	4.47	2.51	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	33.06	4.13	2.07	6.20	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	69.09	33.65	35.69	19.38	3.82	1.02	1.02	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	92.41	34.36	68.96	17.41	4.88	0.46	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	89.15	54.49	88.91	19.47	6.29	0.12	0.47	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	111.57	25.85	35.92	22.31	10.07	0.54	0.82	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	69.71	37.10	19.68	16.87	5.34	1.12	0.56	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	85.23	25.38	15.86	23.05	8.46	0.63	0.00	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	50.90	21.50	21.78	10.89	5.99	0.82	0.54	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	60.37	20.27	11.46	11.90	4.85	0.44	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	66.97	15.11	8.17	16.74	4.49	0.41	1.23	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	65.23	18.25	22.91	13.20	4.66	0.00	0.78	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	124.57	17.85	19.69	16.19	13.06	0.00	0.18	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	74.11	19.50	7.80	0.00	0.00	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	98.07	16.96	11.15	17.89	8.83	1.86	0.70	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	81.04	30.81	23.04	17.09	8.03	1.04	0.52	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	83.00	28.06	22.80	17.53	8.18	0.88	0.58	4.68
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	63.21	5.58	7.44	7.90	5.11	1.86	0.00	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	45.65	7.81	11.52	7.81	4.52	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	57.71	6.14	3.68	5.83	5.83	0.31	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	71.69	15.79	15.36	9.39	6.40	0.43	0.00	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	68.24	14.25	11.83	15.77	5.16	0.61	0.00	3.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	61.86	17.09	15.65	15.41	6.74	1.20	0.48	3.37
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	120.72	20.27	18.04	21.61	10.69	0.45	0.67	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	60.04	19.01	7.34	10.01	6.00	1.67	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	174.67	24.16	5.57	1.86	11.15	0.00	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	85.50	36.54	13.56	11.68	5.27	1.51	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	81.99	16.57	11.34	4.36	6.11	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	133.09	37.49	16.87	9.37	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	72.06	6.59	1.88	8.24	6.36	1.18	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	26.68	8.38	3.72	4.34	1.09	4.50	0.00	1.09
adipose, donor1	10184-103D4	175.92	49.26	47.50	27.56	12.31	0.59	5.28	0.00
adipose, donor2	10185-103D5	35.69	15.00	4.06	5.68	7.70	0.00	0.41	0.41
adipose, donor3	10186-103D6	68.34	18.79	13.61	8.44	5.45	0.00	0.54	0.00
adipose, donor4	10187-103D7	191.55	37.27	6.07	15.60	8.67	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	168.87	8.36	5.37	10.89	14.99	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	82.71	10.27	9.21	8.00	7.60	1.07	0.27	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.09	5.00	7.50	1.79	3.93	0.00	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	34.31	2.78	2.09	5.80	1.85	0.23	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	49.36	11.16	3.04	5.07	1.69	0.34	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	45.07	1.18	2.95	1.18	1.47	1.47	0.29	0.00
amygdala - adult, donor10196	10167-103B5	27.27	5.93	4.74	2.37	3.56	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	37.11	13.38	6.69	6.69	2.03	3.65	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	12.59	4.84	7.42	2.90	1.61	3.23	0.32	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	39.34	9.80	11.71	5.48	2.29	0.00	0.51	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	52.07	13.24	7.28	9.93	4.85	0.88	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	51.78	5.68	23.72	5.34	2.67	0.33	0.00	0.67
aorta, adult, pool1	10052-101G7	44.13	5.88	2.94	2.35	0.59	0.98	0.39	0.00
appendix, adult	10189-103D9	56.67	10.09	14.36	5.43	2.33	2.33	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	48.84	9.63	6.53	6.53	3.44	0.69	0.00	0.00
artery, adult	10190-103E1	23.10	1.36	1.36	2.72	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	38.24	16.66	19.56	5.22	1.59	0.58	0.43	0.29
b cell line:RPMI1788	10427-106D4	91.01	16.21	7.14	11.30	6.39	0.74	0.00	6.10
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.59	2.77	2.77	1.94	0.55	1.11	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	31.16	4.86	9.53	3.87	2.18	0.50	0.00	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	105.62	28.29	27.62	24.60	11.55	1.51	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	48.09	17.34	19.57	7.83	2.80	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	37.05	10.21	4.67	4.35	1.52	0.43	0.11	0.33
blood, adult, pool1	10053-101G8	64.22	4.43	0.00	4.43	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	2.57	0.00	0.86	4.28	0.86	0.00	0.00
bone marrow, adult	10192-103E3	24.97	3.37	5.40	5.40	3.37	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	29.73	8.20	5.13	7.18	1.03	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	38.98	20.38	12.47	14.81	1.89	3.56	0.11	0.89
brain, fetal, pool1	10085-102B4	34.73	26.71	8.01	5.34	0.00	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.61	5.29	0.66	4.29	3.30	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	95.61	39.44	11.73	25.09	5.62	2.00	0.12	0.87
breast, adult, donor1	10080-102A8	22.10	5.05	2.53	4.42	0.00	1.89	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	63.65	6.99	2.54	9.27	4.19	0.13	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	89.98	7.42	10.51	8.35	8.04	0.00	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	84.72	3.68	7.60	7.83	7.60	0.00	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	60.76	10.17	6.54	6.78	4.12	0.73	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	75.70	12.22	7.52	8.46	6.11	0.00	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	75.58	13.56	19.03	19.80	4.16	0.88	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	49.75	17.43	26.62	7.61	1.58	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.06	14.64	30.88	4.26	3.19	0.00	1.33	0.00
caudate nucleus - adult, donor10196	10177-103C6	66.78	9.21	5.76	5.76	4.61	1.15	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	44.01	13.89	11.71	8.20	2.18	3.01	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	51.20	9.17	4.58	4.58	3.06	1.53	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	27.47	10.99	9.89	5.13	4.76	1.10	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	81.57	55.35	14.57	14.57	17.48	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	62.35	44.41	12.38	13.66	1.92	3.84	0.21	0.85
cerebellum, adult, pool1	10083-102B2	50.36	23.80	8.97	13.11	3.45	1.72	2.41	0.34
cerebellum, newborn, donor10223	10357-105E6	24.08	29.89	19.10	6.64	1.66	5.81	0.00	7.47
cerebral meninges, adult	10188-103D8	46.65	11.35	9.33	3.03	3.03	3.53	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	35.08	2.19	0.00	1.46	3.65	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	75.34	14.95	10.35	6.04	4.60	0.58	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	33.14	8.45	14.25	6.13	3.15	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	32.55	12.49	4.83	7.77	2.52	0.63	0.10	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	21.88	7.52	7.25	4.60	1.53	0.14	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	1.31	1.31	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	57.79	8.70	4.85	9.82	4.72	0.00	0.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	55.20	6.41	4.81	7.76	3.20	0.37	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	79.69	3.56	5.93	4.74	2.37	0.00	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	29.63	5.13	1.99	3.99	1.71	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	29.53	8.45	5.67	11.34	1.09	0.80	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	32.97	1.65	3.85	1.10	2.20	0.00	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	43.42	10.10	69.68	3.03	0.00	0.00	7.07	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	63.39	17.67	8.64	11.53	5.76	0.77	0.00	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	64.83	25.34	10.98	10.35	3.59	0.42	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	69.85	10.27	11.81	11.56	3.85	0.51	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	70.39	12.34	10.64	8.47	2.90	0.97	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	64.14	16.70	11.40	5.70	4.48	0.41	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	45.35	12.37	8.24	13.25	3.53	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	79.75	65.94	28.93	20.85	4.17	2.35	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	53.49	2.74	2.97	2.74	3.66	0.69	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	56.91	6.07	4.51	7.81	3.12	0.52	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	55.64	11.90	11.53	9.70	1.65	0.55	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	94.64	14.06	19.00	12.92	10.26	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	40.46	7.14	1.19	5.95	1.19	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	35.13	8.81	3.64	5.99	1.41	1.53	0.00	0.59
colon, fetal, donor1	10070-101I7	37.08	7.42	4.94	9.89	0.00	2.47	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	91.67	13.75	4.58	0.00	4.58	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	41.22	10.20	18.70	10.20	8.50	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	64.45	14.04	19.32	12.07	7.85	0.91	0.75	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	69.38	15.93	25.24	14.38	7.19	2.12	0.28	1.13
corpus callosum, adult, pool1	10042-101F6	48.21	32.84	25.76	11.06	2.99	9.51	0.11	1.88
cruciate ligament, donor2	10295-104G7	42.14	6.48	2.43	4.05	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	38.52	6.42	2.41	4.01	2.41	0.00	0.00	0.80
diencephalon, adult	10193-103E4	47.28	12.00	12.24	3.84	3.12	4.08	0.24	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	73.48	33.06	25.95	13.09	6.66	0.00	2.30	2.53
ductal cell carcinoma cell line:KLM-1	10438-106E6	51.29	6.41	10.77	6.41	4.62	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	23.59	6.02	6.98	4.09	2.17	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	26.41	3.99	3.49	1.50	1.50	1.50	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	34.57	4.32	2.88	0.00	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.25	7.36	7.36	2.21	1.47	1.47	0.74	1.47
dura mater, adult, donor1	10041-101F5	43.36	11.07	4.38	5.45	2.31	0.83	0.00	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	10.44	7.99	26.43	3.33	1.78	1.11	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	34.39	25.94	37.11	14.90	3.44	0.29	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	99.28	3.70	2.47	4.93	5.55	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	45.10	3.03	2.42	3.33	6.66	0.61	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	84.29	2.16	4.01	1.85	4.01	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	66.99	1.31	2.63	1.31	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	51.28	10.06	5.70	8.72	4.36	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	61.98	4.53	3.62	4.53	6.34	0.18	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.43	4.34	3.70	8.04	3.06	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	53.02	14.56	9.12	7.23	3.89	0.67	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.47	19.03	21.45	9.13	3.74	0.00	0.22	0.00
epididymis, adult	10197-103E8	34.54	7.33	3.14	2.72	1.47	2.09	0.00	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	38.50	9.40	4.97	4.08	2.13	0.53	0.18	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	17.30	5.11	3.54	6.69	1.97	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	97.24	15.07	20.18	18.48	6.16	0.00	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	83.07	15.55	20.47	18.40	6.79	0.10	0.30	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	96.23	15.12	16.13	23.30	6.50	0.00	0.78	0.00
esophagus, adult, pool1	10015-101C6	35.57	9.03	2.65	3.72	2.23	0.96	0.53	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	43.83	20.41	5.51	7.01	2.76	0.63	0.00	0.50
eye - muscle inferior rectus, donor1	10272-104E2	57.95	4.83	4.83	2.41	7.24	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	6.31	0.00	6.31	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	72.92	4.46	0.00	5.95	1.49	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	63.06	3.44	2.29	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	67.04	10.20	1.46	4.37	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	50.34	23.14	12.20	8.39	1.78	1.78	1.02	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	36.93	4.74	2.82	5.26	2.44	0.13	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	80.25	7.60	7.60	11.16	7.83	0.24	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	43.72	16.23	9.29	5.91	3.94	3.57	0.19	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	58.85	17.11	9.31	9.01	3.00	0.00	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	32.46	5.21	7.86	4.39	2.01	0.00	0.09	0.18
gall bladder, adult	10198-103E9	30.66	7.24	2.90	2.66	1.45	1.45	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	38.65	15.57	10.74	5.91	2.15	0.54	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	35.48	24.28	7.84	8.59	1.49	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.82	5.49	5.49	3.80	1.69	0.00	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	100.58	10.83	9.67	8.90	5.03	0.19	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	105.26	9.51	15.74	13.77	12.79	0.98	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	81.46	5.49	5.49	2.75	10.07	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	48.43	22.62	19.65	7.54	1.83	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	36.14	5.74	2.29	4.13	1.72	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	70.54	12.32	5.04	12.04	4.76	0.00	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	80.06	6.24	8.23	3.49	9.23	1.50	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.69	3.59	2.85	2.53	1.90	0.11	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.21	3.79	2.67	2.53	2.39	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	42.94	9.82	10.71	5.52	3.42	0.44	0.22	0.11
glioma cell line:GI-1	10413-106B8	29.58	6.74	7.91	4.39	1.46	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	50.29	9.48	7.29	7.29	5.10	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	54.68	27.83	19.28	12.94	2.44	7.32	0.98	0.98
globus pallidus, adult, donor10258	10367-105F7	32.86	21.91	21.91	6.85	5.48	4.11	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	17.05	5.33	4.26	4.80	2.66	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	92.99	14.68	7.34	4.89	14.68	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	10.93	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.92	2.56	3.20	2.56	1.60	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	71.62	9.18	5.05	4.13	2.75	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	67.22	3.20	2.74	3.20	3.66	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	63.12	3.22	5.15	3.86	3.22	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	119.29	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	78.19	5.49	2.06	4.12	2.06	0.00	1.37	0.69
hIPS, biol_rep3	14382-156B8	45.24	3.31	7.72	0.00	0.00	4.41	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	86.49	10.06	8.62	5.75	7.47	0.00	1.15	2.01
heart - mitral valve, adult	10205-103F7	34.38	10.76	6.28	5.98	1.49	2.39	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	45.24	12.03	5.23	6.01	3.92	4.18	0.52	1.31
heart - tricuspid valve, adult	10207-103F9	37.47	8.33	6.66	5.00	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	37.34	4.90	3.06	1.43	1.63	0.41	1.02	0.82
heart, adult, diseased, donor1	10051-101G6	41.31	10.22	4.68	5.11	1.70	1.70	0.00	1.70
heart, adult, pool1	10016-101C7	39.10	7.13	3.45	6.67	1.84	2.53	0.00	0.46
heart, fetal, pool1	10046-101G1	51.96	23.72	18.79	9.14	3.39	3.59	0.21	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	14.50	2.78	1.54	1.23	0.62	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	88.00	9.51	16.65	4.76	4.76	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	62.21	22.32	16.80	19.89	4.31	0.33	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	68.21	21.97	18.81	16.87	4.73	0.24	0.36	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.57	17.79	18.39	20.72	5.25	0.30	0.10	0.30
hepatoma cell line:Li-7	10484-107A7	51.27	13.90	13.79	8.23	3.45	0.00	0.22	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	119.60	27.74	22.91	18.69	7.74	0.30	0.20	0.70
hippocampus - adult, donor10196	10169-103B7	35.01	9.46	14.19	4.73	1.89	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	41.84	15.31	10.20	7.14	1.43	4.90	0.20	1.02
hippocampus, adult, donor10258	10374-105G5	30.87	1.99	4.48	0.50	0.50	6.47	0.00	1.49
hippocampus, newborn, donor10223	10363-105F3	17.98	3.52	5.64	3.17	2.11	1.41	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	177.61	25.02	10.38	25.02	12.82	0.00	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	77.76	12.57	6.09	17.87	7.07	0.39	0.98	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	86.83	11.17	6.09	13.96	7.87	0.51	1.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	69.36	10.71	10.15	9.59	6.20	0.56	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	73.59	15.23	16.78	14.20	5.94	0.00	12.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	64.53	21.26	14.05	16.32	7.21	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	51.97	20.44	24.23	8.76	9.34	0.58	1.75	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.21	21.97	23.05	10.56	8.19	0.43	0.65	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	40.04	19.60	11.26	7.09	5.00	1.67	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	45.94	32.91	42.86	17.52	4.97	1.18	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	50.30	31.18	36.48	10.13	4.02	0.80	0.64	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.17	28.95	40.40	18.18	3.37	0.00	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	69.79	11.58	4.85	13.61	6.26	0.00	0.78	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	86.96	6.88	7.37	9.83	5.40	0.49	6.39	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	108.22	20.07	6.11	34.91	7.85	1.75	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	67.96	18.33	14.89	15.27	7.64	0.19	2.48	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.92	11.34	11.77	11.34	6.54	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	83.46	21.99	21.99	18.99	3.00	0.50	7.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	54.07	18.84	16.58	10.74	7.35	0.19	1.32	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	48.65	20.92	18.64	8.64	6.37	0.45	1.82	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	51.06	18.79	16.29	6.26	5.64	0.31	2.19	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	32.66	17.31	19.11	7.84	4.08	0.16	0.49	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	36.00	15.68	18.29	4.94	3.77	0.58	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	28.70	16.74	15.54	8.07	3.29	0.60	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	89.60	15.33	6.10	19.58	7.76	0.55	1.48	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	75.89	10.56	5.71	13.41	5.42	0.29	0.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	126.58	22.87	9.80	25.32	12.25	2.04	3.67	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	58.09	13.73	16.55	11.27	3.52	0.35	5.28	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	48.46	13.94	9.50	9.82	2.85	0.00	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	62.34	16.04	18.16	9.99	4.84	0.61	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	37.23	13.45	16.55	6.72	4.14	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	45.83	12.62	9.96	7.97	4.65	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	44.12	23.09	17.19	11.54	5.13	0.51	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	35.79	15.08	18.92	4.86	3.83	0.00	2.30	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	14.39	21.96	6.82	6.82	0.00	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.20	14.79	21.17	4.37	4.37	0.67	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	86.22	12.56	4.59	11.11	7.25	0.72	0.72	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	90.91	19.16	8.02	15.15	10.25	0.45	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	81.95	11.71	7.32	11.71	9.27	0.00	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	55.01	14.67	17.42	14.98	4.28	0.00	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	474.97	172.42	257.01	100.85	48.80	0.00	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	83.73	29.12	28.13	20.85	6.95	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	62.39	13.68	26.82	9.30	6.57	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	45.24	22.80	18.82	9.41	6.88	1.09	1.81	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	46.98	15.66	21.71	10.32	4.98	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	7.16	17.90	7.16	7.16	0.00	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.58	29.66	42.39	12.19	4.74	0.95	0.81	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.40	15.09	27.48	6.47	4.85	1.08	0.81	0.00
immature langerhans cells, donor1	11904-125F5	26.88	2.42	2.18	3.39	2.42	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	18.22	2.38	1.58	0.79	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	45.52	15.43	7.76	6.34	3.60	3.31	0.19	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	20.81	0.33	0.33	1.95	0.98	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	35.45	9.71	5.81	5.61	1.30	2.70	0.10	1.10
kidney, fetal, pool1	10045-101F9	31.97	15.21	9.90	5.31	1.91	1.49	0.07	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	34.37	9.37	9.94	4.12	2.84	0.57	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.86	3.73	4.70	2.07	2.49	0.00	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	33.58	4.59	4.77	2.57	4.04	0.73	0.37	0.37
left atrium, adult, donor1	10079-102A7	28.88	7.08	1.63	4.36	1.09	1.63	0.00	1.09
left ventricle, adult, donor1	10078-102A6	42.47	6.07	3.03	5.56	3.54	3.03	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	73.33	12.86	5.20	11.22	4.65	0.82	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	11.14	1.44	0.72	1.80	0.72	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	8.70	1.09	1.63	2.17	1.63	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	10.68	2.19	1.70	2.43	0.97	0.24	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	1.05	1.05	1.05	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	61.39	24.79	10.03	6.97	2.83	1.06	0.35	0.59
liposarcoma cell line:KMLS-1	10782-110G8	22.49	2.97	1.72	2.34	1.72	0.16	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	43.74	9.02	15.11	7.92	2.31	0.49	0.00	0.24
liver, adult, pool1	10018-101C9	29.33	6.81	4.86	6.32	0.97	0.97	0.00	0.32
liver, fetal, pool1	10086-102B5	31.04	5.64	3.76	4.70	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	35.73	16.19	11.81	7.00	1.75	3.94	0.29	0.87
locus coeruleus, adult, donor10252	10165-103B3	28.97	16.06	8.49	8.30	2.03	1.85	0.18	0.92
locus coeruleus, adult, donor10258	10375-105G6	19.19	12.13	5.92	7.34	0.85	3.67	1.69	0.85
locus coeruleus, newborn, donor10223	10362-105F2	25.66	15.56	10.09	2.94	3.36	2.52	0.00	2.10
lung adenocarcinoma cell line:A549	10499-107C4	59.23	4.98	4.29	6.64	5.95	0.69	0.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	42.05	6.20	4.14	4.83	4.83	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	54.70	3.43	8.57	8.83	5.54	0.79	0.13	0.53
lung, adult, pool1	10019-101D1	36.86	7.91	6.50	7.44	2.24	1.18	0.00	0.59
lung, fetal, donor1	10068-101I5	63.65	11.42	28.83	4.57	2.00	0.57	0.29	1.43
lung, right lower lobe, adult, donor1	10075-102A3	29.33	9.62	1.83	6.42	2.75	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	32.66	4.26	3.79	8.99	1.89	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	48.22	14.68	8.99	9.86	1.97	0.22	0.66	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	168.59	52.67	76.67	32.90	9.21	1.81	0.91	2.57
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	30.58	9.34	8.49	11.04	1.70	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	23.53	9.77	2.22	6.22	0.44	12.43	0.00	1.78
mature adipocyte, donor2	12232-129F9	21.17	5.19	1.45	4.36	1.66	13.07	0.21	4.77
mature adipocyte, donor3	12233-129G1	22.28	4.50	1.66	1.19	1.19	11.62	0.00	4.27
mature adipocyte, donor4	12234-129G2	36.32	10.79	4.47	6.58	2.37	9.74	0.26	3.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	54.08	6.91	10.01	3.81	5.48	0.24	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	42.87	10.15	9.02	7.90	2.26	3.38	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	34.76	14.16	9.75	7.91	0.55	3.86	0.37	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	27.00	5.08	3.81	1.59	2.22	3.49	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	43.50	15.35	18.34	9.38	2.99	3.84	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	38.64	12.83	8.78	5.06	2.53	3.04	2.19	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	40.53	12.73	8.70	8.91	2.97	3.82	0.00	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	3.85	5.78	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	244.01	129.18	100.48	28.71	14.35	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	23.33	8.61	6.10	3.23	1.08	3.59	0.00	2.51
medulla oblongata - adult, donor10196	10174-103C3	31.15	12.98	6.49	5.19	3.89	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	39.63	17.03	10.53	8.67	1.86	5.11	0.15	1.39
medulla oblongata, adult, pool1	10038-101F2	39.43	20.90	14.45	7.59	2.53	6.37	0.16	1.88
medulla oblongata, newborn, donor10223	10361-105F1	18.05	7.29	5.55	5.21	1.39	1.39	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	62.66	35.65	17.27	14.17	3.99	1.33	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	50.74	7.70	7.34	7.83	4.04	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	24.72	7.04	7.91	3.59	2.30	0.57	0.00	0.29
melanoma cell line:G-361	10465-106H6	47.78	7.87	7.60	2.44	5.43	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	23.70	5.25	5.79	3.26	1.27	0.36	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	72.25	46.70	37.01	18.50	10.57	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	59.62	31.37	27.48	10.11	3.63	0.52	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	30.23	3.99	5.37	4.76	1.84	0.31	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.45	2.54	3.45	2.00	0.55	0.00	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	0.41	2.07	2.90	0.83	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.84	1.97	0.70	2.67	0.42	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	13.29	3.47	1.16	1.35	0.77	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.02	2.08	2.08	0.00	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.16	2.06	1.20	1.37	0.86	0.34	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.15	2.19	1.61	1.61	0.69	0.23	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	28.65	4.77	5.17	3.58	1.46	0.00	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.55	1.89	3.11	3.65	2.03	0.27	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.19	2.28	3.13	2.70	1.00	0.00	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.56	1.32	1.65	0.99	0.66	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	24.91	1.94	4.70	5.40	0.69	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.58	4.54	2.09	3.84	1.75	0.00	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.99	3.27	2.65	1.84	0.41	0.41	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	9.35	2.88	1.44	3.24	0.00	0.00	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.10	2.38	1.45	1.45	0.62	0.21	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.35	2.05	2.51	2.05	0.91	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	47.83	7.13	5.03	9.65	2.94	0.00	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.82	2.84	3.14	3.14	1.05	0.00	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.09	2.71	3.15	2.71	0.70	0.18	0.00	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.15	3.31	2.21	1.47	1.47	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.16	3.43	2.29	1.43	0.29	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.16	6.74	11.79	2.95	2.53	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	1.83	3.65	1.83	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.95	4.86	3.07	1.28	0.77	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.97	6.54	2.36	3.14	0.52	0.26	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.33	6.16	0.92	3.39	2.16	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.30	6.12	2.35	2.12	0.94	0.47	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.26	4.06	2.71	3.38	0.68	1.35	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	3.93	1.57	1.96	1.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.90	2.78	3.24	3.24	0.93	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	21.34	4.90	3.17	4.33	0.87	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.18	4.46	3.12	2.90	0.45	0.00	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.47	4.09	2.64	2.64	0.72	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.20	5.13	4.40	2.20	2.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.77	2.35	2.01	1.34	0.67	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	6.96	2.87	4.09	0.82	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.89	4.30	2.58	3.87	2.15	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	0.00	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	5.16	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.59	4.87	1.95	1.95	0.97	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	1.45	0.00	0.00	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	16.53	3.20	2.67	2.13	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	3.27	5.72	1.64	1.64	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	3.11	2.72	1.17	0.39	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	0.00	2.10	2.10	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	3.97	2.98	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	4.77	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.64	2.37	1.19	2.37	1.19	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	3.66	1.22	2.44	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	3.17	1.27	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	2.76	3.10	0.34	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	4.30	0.00	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	3.44	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	1.22	1.22	1.22	0.41	0.00	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	2.38	3.18	0.79	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	1.77	2.36	1.77	0.00	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.91	3.43	1.87	1.56	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	2.67	5.35	0.00	0.00	1.34	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	5.91	1.18	1.18	3.55	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	12.84	5.14	2.57	2.57	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	11.01	2.75	2.75	0.69	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.82	8.91	5.94	5.44	0.49	1.98	0.49	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	5.61	2.24	1.12	3.36	1.12	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	8.27	7.63	3.18	1.91	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.49	5.24	1.61	4.03	0.81	2.01	0.40	2.42
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	4.36	2.18	2.18	2.18	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	5.07	0.00	5.07	1.27	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.39	3.03	1.21	2.43	1.21	5.46	0.61	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	3.29	2.47	1.65	0.82	2.47	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.29	5.95	1.59	3.77	0.40	0.99	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.36	3.24	1.95	1.62	1.62	0.00	0.32	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	6.11	2.04	1.02	1.02	2.04	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	24.76	3.09	0.77	3.87	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	58.59	5.67	3.78	3.54	4.96	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	37.99	8.34	5.79	9.04	3.71	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	21.37	12.82	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	28.98	10.17	10.79	8.73	2.67	0.41	0.21	0.72
mesothelioma cell line:Mero-25	10850-111F4	18.61	3.86	11.57	3.86	2.27	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	30.80	5.38	3.91	4.65	2.20	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	15.50	1.77	2.66	0.44	1.11	0.44	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	24.70	8.67	13.67	5.78	2.10	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	27.41	6.81	9.53	4.94	2.04	0.17	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	27.05	2.78	1.52	4.55	1.77	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	33.13	4.55	4.76	2.90	1.45	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	20.21	4.14	2.82	0.99	2.65	0.33	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	29.86	7.78	7.96	3.08	1.63	0.18	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	43.05	7.86	8.54	5.30	4.61	0.85	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	47.08	6.62	5.60	6.11	4.33	0.25	0.76	0.76
mesothelioma cell line:No36	10857-111G2	25.12	5.22	6.20	3.59	2.28	0.65	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	12.19	1.08	1.90	2.71	0.00	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	62.57	4.99	6.14	4.61	3.45	0.38	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	32.36	2.44	2.08	2.56	2.81	0.49	0.00	0.49
migratory langerhans cells, donor3	11903-125F4	39.31	5.74	4.85	3.95	3.05	0.72	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.24	8.81	9.14	4.90	2.61	0.00	1.63	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.17	9.11	6.36	2.12	2.54	0.42	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	89.15	6.68	6.91	10.37	10.83	0.23	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.63	5.14	5.71	4.76	2.66	0.38	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	104.41	41.39	35.11	27.16	7.95	0.74	1.29	1.11
myeloma cell line:PCM6	10474-106I6	49.22	14.83	4.94	14.03	2.77	0.59	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	93.34	5.58	9.13	4.06	4.06	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.52	6.86	2.55	1.96	0.20	0.20	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.07	2.79	2.12	3.45	2.56	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.09	3.31	3.02	2.72	2.35	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	81.69	9.38	0.00	6.62	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	60.05	24.85	17.94	12.88	4.37	0.92	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	86.99	43.78	19.46	14.59	4.86	0.37	0.19	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	45.13	11.81	25.10	2.74	1.27	0.21	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	45.66	35.59	26.28	10.44	2.05	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	53.61	23.72	23.72	8.54	1.42	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	49.57	24.71	21.22	6.97	3.64	0.32	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	50.92	26.37	10.87	11.07	3.22	0.20	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	83.29	10.81	10.81	5.72	4.45	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.29	4.52	3.46	2.40	2.13	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	9.47	9.47	18.94	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	164.89	45.66	24.35	25.20	6.60	1.01	0.34	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	21.61	5.60	12.81	6.40	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.99	5.13	3.21	2.89	0.96	0.00	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.98	2.63	1.31	1.58	0.53	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	43.31	16.59	8.72	5.81	2.81	3.09	0.09	0.94
occipital cortex - adult, donor10196	10172-103C1	51.51	8.24	8.24	0.00	4.12	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	40.25	17.98	13.42	8.59	0.81	4.29	0.00	1.34
occipital cortex, newborn, donor10223	10355-105E4	27.30	4.73	4.73	2.91	4.00	3.64	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	44.61	14.43	7.61	6.56	3.41	2.36	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	61.36	27.03	14.59	17.59	6.44	1.29	0.86	0.43
occipital pole, adult, pool1	10036-101E9	35.64	8.99	6.54	3.23	2.37	2.52	0.16	1.34
olfactory region, adult	10195-103E6	36.49	11.85	8.22	6.69	2.87	4.01	0.19	0.96
optic nerve, donor1	10277-104E7	42.02	38.02	16.01	6.00	6.00	8.00	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	52.51	10.14	12.99	6.26	3.30	0.68	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	47.54	3.71	3.98	6.87	3.16	0.14	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.43	8.13	4.91	3.73	2.54	0.17	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	38.93	5.89	7.05	3.70	2.08	0.35	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	19.40	5.29	3.82	1.18	2.35	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	52.32	10.28	20.56	8.41	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	19.72	16.75	12.30	5.51	1.27	0.85	0.00	0.21
ovary, adult, pool1	10020-101D2	27.25	12.40	6.20	7.77	1.48	0.61	0.00	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.70	3.85	4.77	2.93	3.48	0.18	0.18	0.00
pancreas, adult, donor1	10049-101G4	35.74	4.70	3.76	4.70	0.94	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.34	3.63	3.63	3.35	1.12	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	16.52	4.77	5.28	1.70	0.51	0.17	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	33.45	7.29	10.60	3.64	2.32	1.16	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	41.37	13.82	10.43	4.76	2.47	4.12	0.00	0.82
parietal cortex, adult, donor10258	10373-105G4	49.91	8.07	5.14	1.47	2.94	4.40	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	32.92	14.11	2.82	4.70	0.00	3.76	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	42.47	13.97	10.55	6.84	1.43	4.28	0.00	1.71
parietal lobe, adult, pool1	10034-101E7	40.01	12.87	8.37	6.87	1.32	3.79	0.00	1.23
parietal lobe, fetal, donor1	10072-101I9	48.49	29.10	27.16	10.67	9.70	1.94	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	20.19	7.48	7.48	2.99	4.11	0.75	0.00	1.12
parotid gland, adult	10199-103F1	33.92	3.70	4.32	4.32	1.23	1.85	0.00	0.62
penis, adult	10200-103F2	25.24	8.06	3.22	3.22	1.07	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	19.71	7.81	25.29	3.35	0.56	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	41.09	5.68	4.52	4.66	3.79	0.73	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	44.51	14.84	5.16	7.74	2.58	1.94	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	80.54	25.47	10.07	8.29	3.55	1.18	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	49.54	9.41	3.14	6.90	1.88	3.14	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	38.45	14.17	9.11	4.05	3.04	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	48.99	17.72	8.86	2.08	1.56	3.65	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	29.79	5.96	0.00	5.96	2.55	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	31.28	8.28	4.62	13.12	2.26	1.29	0.00	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	66.48	10.20	14.70	6.62	5.03	0.93	0.00	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.70	2.33	1.71	1.09	0.16	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	27.89	14.03	10.76	3.87	2.75	3.53	0.00	1.64
postcentral gyrus, adult, pool1	10032-101E5	32.69	12.47	7.67	5.93	1.83	3.75	0.09	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	2.09	6.27	6.27	8.37	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	11.02	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	35.21	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	103.42	8.59	8.16	11.36	14.42	0.15	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	64.61	9.62	7.99	8.35	3.27	0.36	0.18	0.00
prostate, adult, pool1	10022-101D4	31.02	8.89	5.44	5.35	1.72	1.81	0.09	0.73
putamen, adult, donor10196	10176-103C5	66.33	19.59	7.32	12.98	4.96	4.49	0.00	0.47
putamen, adult, donor10252	10152-102I8	27.45	9.80	5.88	7.84	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	50.27	4.37	3.28	1.09	4.37	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	55.09	7.73	6.04	3.38	2.17	1.93	0.48	0.00
putamen, newborn, donor10223	10365-105F5	31.49	18.74	15.74	9.00	1.50	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.35	4.36	11.93	2.62	2.62	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	77.90	15.30	6.95	4.17	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	35.40	5.30	3.82	4.24	2.76	0.42	0.00	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.44	1.66	1.24	0.83	2.07	0.41	0.41	0.00
retina, adult, pool1	10030-101E3	37.08	15.51	10.34	7.85	3.48	3.18	0.10	1.59
retinoblastoma cell line:Y79	10475-106I7	124.19	51.44	30.66	24.68	6.24	0.26	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	74.63	13.77	13.40	15.49	5.04	0.37	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	71.71	25.87	20.25	10.12	6.47	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.01	4.55	4.55	0.76	3.03	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	20.88	4.05	3.40	1.94	1.94	0.00	0.00	0.16
salivary acinar cells, donor2	11772-123I8	20.38	3.86	3.03	2.34	1.79	0.14	0.00	0.28
salivary acinar cells, donor3	11773-123I9	27.14	2.65	1.32	0.66	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	22.31	0.00	4.58	1.72	0.57	0.00	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	18.21	3.63	2.78	1.69	0.76	0.17	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.51	2.94	2.35	2.35	1.29	0.24	0.00	0.00
seminal vesicle, adult	10201-103F3	39.68	6.88	4.76	2.65	1.06	2.12	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.33	1.94	0.97	1.46	0.73	0.24	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	3.52	2.01	1.26	1.26	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	32.11	8.03	4.01	3.01	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	28.74	5.91	3.22	4.16	2.01	0.54	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	44.65	6.19	10.94	6.96	3.09	0.33	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	41.03	5.03	4.39	5.94	4.13	0.39	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	68.10	3.55	2.13	7.80	4.97	0.00	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	35.38	7.32	4.08	5.88	2.16	2.16	0.12	1.08
skeletal muscle, fetal, donor1	10066-101I3	36.18	13.07	5.03	5.03	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	57.44	15.78	8.84	5.05	3.79	3.16	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	39.69	8.00	6.34	8.34	2.67	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	48.23	40.66	35.30	7.88	2.21	0.00	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	167.88	9.06	4.63	7.90	23.71	0.39	1.16	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	96.09	25.05	64.94	11.87	7.25	0.66	0.49	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	115.97	23.16	19.78	11.90	13.51	0.00	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	44.89	5.01	11.33	3.49	2.62	0.44	0.44	0.44
small intestine, adult, pool1	10024-101D6	48.73	9.91	3.94	6.33	1.67	1.67	0.24	1.43
small intestine, fetal, donor1	10064-101I1	44.72	13.27	8.60	5.16	2.95	2.95	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	33.34	9.75	4.10	2.56	2.05	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	40.32	8.27	4.91	1.81	1.03	1.03	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	68.88	5.36	2.14	4.82	5.36	0.27	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	36.48	21.11	11.70	7.11	3.21	6.19	0.23	0.69
spinal cord, adult, donor10252	10159-103A6	50.47	22.87	14.59	8.67	3.15	6.31	0.00	2.37
spinal cord, adult, donor10258	10369-105F9	49.12	13.14	13.84	2.08	1.38	6.23	0.69	2.08
spinal cord, fetal, donor1	10056-101H2	42.08	16.47	6.71	3.05	1.83	0.61	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	43.63	16.99	16.07	7.81	3.21	2.76	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.31	4.63	1.79	2.99	1.34	0.30	0.30	0.30
spleen, adult, pool1	10025-101D7	39.32	13.66	5.40	6.50	0.99	0.77	0.00	0.77
spleen, fetal, pool1	10044-101F8	37.19	12.32	8.50	7.31	1.59	0.56	0.08	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	78.88	19.56	6.42	11.59	7.04	0.52	0.00	1.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	30.57	0.76	2.09	2.66	1.90	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.72	3.15	2.80	3.49	2.10	1.40	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.54	5.08	7.04	1.56	0.78	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	72.60	29.38	21.50	12.83	4.28	0.68	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	49.56	10.17	7.20	14.40	3.39	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.08	3.38	5.08	8.04	1.27	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	58.74	7.48	7.48	1.07	1.07	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	31.90	7.41	3.99	3.99	2.28	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	108.55	54.27	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	35.52	20.98	20.56	11.63	1.87	5.19	0.62	0.83
substantia nigra, adult, donor10258	10371-105G2	30.52	7.76	6.21	2.07	1.55	1.55	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	16.96	7.07	6.36	4.95	2.12	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	70.84	18.57	25.91	12.15	5.73	0.46	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	34.76	12.21	6.36	3.73	2.29	2.97	0.17	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	49.86	22.79	17.09	2.14	4.99	1.42	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	44.39	21.98	14.50	2.64	5.27	3.08	0.00	0.44
tenocyte, donor1	11763-123H8	19.20	4.19	2.79	2.79	0.35	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	10.30	3.43	0.76	0.00	0.76	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	12.23	3.34	0.74	1.85	0.74	0.37	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	169.11	22.09	15.47	15.47	9.35	0.17	0.34	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	44.70	16.03	7.86	10.48	3.70	0.00	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	68.97	12.71	5.42	9.45	3.41	0.00	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	27.42	2.79	2.16	3.30	0.13	0.00	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	63.91	5.29	1.51	5.67	4.16	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	44.93	3.49	5.56	3.82	1.20	0.22	0.11	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	44.95	6.84	4.89	9.45	2.93	1.30	1.30	0.98
testis, adult, pool1	10026-101D8	20.40	4.62	3.22	3.76	1.40	1.40	0.00	0.21
testis, adult, pool2	10096-102C6	22.10	4.96	1.35	0.90	0.90	1.35	0.00	0.00
thalamus - adult, donor10196	10168-103B6	43.06	18.77	15.46	8.83	0.00	4.42	0.00	2.21
thalamus, adult, donor10252	10154-103A1	45.79	25.01	18.91	12.66	1.88	7.03	0.00	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	1.54	4.62	3.08	3.08	9.24	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	15.97	9.22	4.12	3.46	0.99	2.64	0.99	0.49
thalamus, newborn, donor10223	10366-105F6	17.83	8.63	4.60	4.60	2.30	0.58	0.00	1.15
throat, adult	10209-103G2	37.20	4.74	3.75	3.99	1.75	1.00	0.00	0.50
throat, fetal, donor1	10061-101H7	50.58	14.93	8.53	5.18	1.83	0.30	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	92.81	13.32	19.08	12.52	8.74	0.40	0.60	0.00
thymus, adult, pool1	10027-101D9	60.94	38.87	57.26	10.74	3.38	1.29	0.20	0.80
thymus, fetal, pool1	10043-101F7	51.02	34.70	49.98	9.77	2.60	0.94	0.00	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	24.73	6.91	7.45	4.65	1.46	0.00	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	47.08	10.48	7.82	7.96	3.63	0.14	0.28	0.70
thyroid, adult, pool1	10028-101E1	36.58	12.41	9.14	4.29	1.87	2.33	0.09	0.84
thyroid, fetal, donor1	10060-101H6	50.89	5.80	5.80	2.37	3.16	0.53	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	0.00	0.00	6.16	3.08	6.16	0.00	0.00
tongue, adult	10203-103F5	24.19	4.19	1.86	2.09	2.56	1.63	0.00	0.47
tongue, fetal, donor1	10059-101H5	48.08	13.40	6.70	10.25	1.18	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	46.58	12.92	7.81	5.01	2.40	1.10	0.10	1.00
trachea, adult, pool1	10029-101E2	26.99	5.64	3.11	2.70	1.15	1.23	0.00	0.08
trachea, fetal, donor1	10058-101H4	35.39	8.46	4.62	2.31	1.54	0.00	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	22.67	2.48	1.77	1.77	1.77	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	50.15	14.79	26.85	10.64	3.55	0.10	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.01	9.24	5.64	5.33	3.45	0.47	0.16	0.63
tridermal teratoma cell line:HGRT	10694-109G1	57.08	5.71	7.61	5.71	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	40.21	3.98	2.45	4.74	2.03	0.25	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17	4.17	4.17	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	32.25	4.10	6.83	3.07	1.19	0.68	0.00	0.34
uterus, fetal, donor1	10055-101H1	56.82	16.89	8.70	4.10	3.58	0.51	0.00	0.00
vagina, adult	10204-103F6	38.77	7.11	2.58	2.58	0.65	1.94	0.00	0.00
vein, adult	10191-103E2	31.56	12.93	8.11	4.38	1.97	2.19	0.22	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	55.01	8.55	5.87	6.41	1.60	0.27	0.80	0.80